Amino Acids, Peptides, and Proteins

Amino acids and chains of amino acids connected by peptide linkages.
DrugDrug NameDrug Indication
DB00001LepirudinFor the treatment of heparin-induced thrombocytopenia
DB00002CetuximabCetuximab, used in combination with irinotecan, is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma in patients who are refractory to irinotecan-based chemotherapy. Cetuximab administered as a single agent is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma in patients who are intolerant to irinotecan-based chemotherapy.
DB00003Dornase alfaUsed as adjunct therapy in the treatment of cystic fibrosis.
DB00004Denileukin diftitoxFor treatment of cutaneous T-cell lymphoma
DB00005EtanerceptEtanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and chronic moderate to severe plaque psoriasis in adults. It is also used to manage signs and symptoms of polyarticular idiopathic arthritis in those aged 4 to 17 after insufficient response to one or more disease-modifying anti-rheumatic drugs. Etanercept is also used to improve psoriatic arthritis and ankylosing spondylitis.
DB00006BivalirudinFor treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.
DB00007LeuprolideFor treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty
DB00008Peginterferon alfa-2aPeginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation [FDA Label].
DB00009AlteplaseFor management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli
DB00010SermorelinFor the treatment of dwarfism, prevention of HIV-induced weight loss
DB00011Interferon alfa-n1For treatment of venereal or genital warts caused by the Human Papiloma Virus
DB00012Darbepoetin alfaFor the treatment of anemia (from renal transplants or certain HIV treatment)
DB00013UrokinaseUrokinase can be used for the treatment of pulminary embolism, coronary artery thrombosis, IV catheter clearance, and venous and arterial blood clots.
DB00014GoserelinUsed to treat hormone-sensitive cancers of the breast (in pre- and peri- menopausal women) and prostate, and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). In addition, goserelin is used in assisted reproduction and in the treatment of precocious puberty.
DB00015ReteplaseFor lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
DB00016ErythropoietinFor use in the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adult and paediatric patients. Also for use in the treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy). Also for used to increase the yield of autologous blood from patients in a predonation program. When administered subcutaneously, Epoetin Zeta is equivalent to Epoetin Alfa in terms of clinical effectiveness.
DB00017Salmon CalcitoninUsed in the treatment of symptomatic Paget's disease for patients unresponsive to alternate treatments or intolerant to such treatments. In addition, it is used in emergency situations when serum calcium levels must be decreased quickly until the underlying condition is identified. It can also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents. Calcitonin can be used in patients with azotemia and cases where intravenous fluids would be contraindicated due to limited cardiac reserves. Also for the treatment of post-menopausal osteoporosis in women more than 5 years post-menopause.
DB00018Interferon alfa-n3For the intralesional treatment of refractory or recurring external condylomata acuminata.
DB00019PegfilgrastimIncreases leukocyte production, for treatment in non-myeloid cancer, neutropenia and bone marrow transplant.
DB00020SargramostimFor the treatment of cancer and bone marrow transplant
DB00021SecretinFor diagnosis of pancreatic exocrine dysfunction and gastrinoma
DB00022Peginterferon alfa-2bPeginterferon alfa-2b is indicated for the treatment of HCV in combination with [DB00811] and a NS3/4A protease inhibitor for genotype 1 or without a NS3/4A protease inhibitor for genotypes 2-6 [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.
DB00024Thyrotropin AlfaFor detection of residueal or recurrent thyroid cancer
DB00025Antihemophilic factor, human recombinantFor the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.
DB00026AnakinraFor the treatment of adult rheumatoid arthritis and treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
DB00027Gramicidin DFor treatment of skin lesions, surface wounds and eye infections.
DB00028Immune Globulin HumanIVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thrombocytopenic purpura, Kawasaki disease, hypogammaglobulinemia, B cell chronic lymphocytic leukemia, bone marrow transplant complications, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), multiple sclerosis, rheumatoid arthritis, myesthenia gravis, Wiskott–Aldrich syndrome and inflammatory skin diseases.
DB00029AnistreplaseFor lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
DB00030Insulin HumanIndicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 and type 2 diabetes mellitus.
DB00031TenecteplaseFor treatment of myocardial infarction and lysis of intracoronary emboli
DB00032MenotropinsFor the treatment of female infertility
DB00033Interferon gamma-1bInterferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis.
DB00034Interferon Alfa-2a, RecombinantFor the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.
DB00035DesmopressinOral formulations may be used to manage primary nocturnal enuresis in adults and vasopressin sensitive diabetes insipidus, and for control of temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. Intranasal and parenteral formulations may be used to manage spontaneous or trauma-induced bleeds (e.g. hemarthrosis, intramuscular hematoma, mucosal bleeding) in patients with hemophilia A or von Willebrand's disease Type I. May also be used parenterally to prevent or treat bleeding in patients with uremia.
DB00036Coagulation factor VIIa Recombinant HumanFor treatment of hemorrhagic complications in hemophilia A and B
DB00038OprelvekinIncreases reduced platelet levels due to chemotherapy
DB00039PaliferminFor treatment of oral mucositis associated with chemotherapy and radiation therapy.
DB00040Glucagon recombinantFor treatment of severe hypoglycemia, also used in gastrointestinal imaging
DB00041AldesleukinFor treatment of adults with metastatic renal cell carcinoma.
DB00042Botulinum Toxin Type BFor the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
DB00043OmalizumabFor treatment of asthma caused by allergies
DB00044Lutropin alfaFor treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L)
DB00046Insulin LisproFor the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a continuous insulin infusion pump.
DB00047Insulin GlargineFor the treatment of Type 1 or 2 diabetes mellitus in patients over 17 years old who require a long-acting (basal) insulin for the control of hyperglycemia. May be used in pediatric patients with Type 1 diabetes mellitus who require a long-acting (basal) insulin for glycemic control.
DB00050CetrorelixFor the inhibition of premature LH surges in women undergoing controlled ovarian stimulation
DB00051AdalimumabFor treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
DB00052SomatotropinFor treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
DB00054AbciximabAbciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours. Abciximab is intended for use with aspirin and heparin and has been studied only in that setting.
DB00055Drotrecogin alfaFor reduction of mortality in patients with severe sepsis.
DB00056Gemtuzumab ozogamicinIndicated for the treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for other cytotoxic chemotherapy. Indicated for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory).
DB00057Indium In-111 satumomab pendetideFor diagnosis of extrahepatic malignant cancers
DB00058Alpha-1-proteinase inhibitorFor chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema.
DB00060Interferon beta-1aFor treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum
DB00062Human Serum AlbuminFor treatment of severe blood loss, hypervolemia, and hypoproteinemia.
DB00063EptifibatideFor treatment of myocardial infarction and acute coronary syndrome.
DB00065InfliximabTo manage the signs and symptoms, as well as to induce and maintain clinical remission in adults with moderate to severe active Crohn's disease or ulcerative colitis. Also used to manage signs and symptoms of rheumatoid arthritis (in conjunction with methotrexate), ankylosing spondylitis, psoriatic arthritis, and juvenile arthritis.
DB00066FollitropinIn women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).
DB00067VasopressinFor the treatment of enuresis, polyuria, diabetes insipidus, polydipsia and oesophageal varices with bleeding
DB00068Interferon beta-1bInterferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks.
DB00069Interferon alfacon-1For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma
DB00070HyaluronidaseFor increase of absorption and distribution of other injected drugs and for rehydration.
DB00071Insulin PorkFor the treatment of type I and II diabetes mellitus.
DB00072TrastuzumabFor treatment of early stage HER2-positive breast cancer, or metastatic breast cancer that substantially overexpress HER2.
DB00073RituximabFor treatment of CD20-positive non-Hodgkins lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.
DB00074BasiliximabFor prophylactic treatment of kidney transplant rejection
DB00075MuromonabFor treatment of organ transplant recipients, prevention of organ rejection
DB00078Ibritumomab tiuxetanFor treatment of non-Hodgkin's lymphoma
DB00080DaptomycinFor the treatment of complicated skin and skin structure infections caused by susceptible strains of Gram-positive microorganisms.
DB00081TositumomabFor treatment of non-Hodgkin's lymphoma (CD20 positive, follicular)
DB00082PegvisomantPegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.
DB00083Botulinum Toxin Type AFor the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia. Also for the treatment of severe primary axillary hyperhidrosis that is inadequately managed with topical agents and for the treatment of strabismus and blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in patients 12 years of age and above. Also used cosmetically to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines) as well as for the treatment of excessive underarm sweating.
DB00086StreptokinaseFor the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae
DB00087AlemtuzumabAlemtuzumab (Campath) is a monoclonal antibody therapy used for treatment of B-cell chronic lymphocytic leukemia.
DB00089Capromab pendetideFor diagnosis of prostate cancer and detection of intra-pelvic metastases.
DB00091CyclosporineFor treatment of transplant (kidney, liver, and heart) rejection, rheumatoid arthritis, severe psoriasis.
DB00092AlefaceptAs an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis
DB00093FelypressinFor use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
DB00094UrofollitropinFor treatment of female infertility
DB00095EfalizumabFor the treatment of adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy.
DB00098Antithymocyte immunoglobulin (rabbit)For prevention of renal transplant rejection
DB00099FilgrastimFilgrastim is used in patients with acute myeloid leukemia receiving induction or consolidation chemotherapy. It is also used in cancer patients receiving bone marrow transplant. In general, filgrastim increases neutrophil counts in order to decrease the risk of infection or duration of neutropenia in the aforementioned patient populations. Infection and neutropenia are adverse events associated with chemotherapy. Furthermore, filgrastim is also indicated for patients with severe chronic neutropenia. It mobilizes hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis to allow for a more rapid engraftment. Tbo-filgrastim has a narrower indication profile than Neupogen - it is a leukocyte growth factor indicated for the reduction in the duration of severe neutropenia in patients with non-myeloid malignancies.
DB00102BecaplerminFor topical treatment of skin ulcers (from diabetes)
DB00103Agalsidase betaFor treatment of Fabry's disease (alpha-galactosidase A deficiency)
DB00104OctreotideFor treatment of acromegaly and reduction of side effects from cancer chemotherapy
DB00105Interferon Alfa-2b, RecombinantFor the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma.
DB00106AbarelixFor palliative treatment of advanced prostate cancer.
DB00107OxytocinUsed for labor induction, augmentation of labor, postpartum abbreviation of third stage of labor, postpartum control of uterine bleeding, termination of pregnancy and for the evaluation of fetal respiratory capability. Oxytocin cannot be used for elective induction of labor, there must be a clear medical requirement.
DB00108NatalizumabFor treatment of multiple sclerosis.
DB00109EnfuvirtideEnfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS.
DB00110PalivizumabFor prophylaxis of respiratory diseases casued by respiratory syncytial virus.
DB00111DaclizumabZenapax is a humanized monoclonal antibody used for prevention of renal transplant rejection
DB00112BevacizumabAs part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.
DB00113Technetium Tc-99m arcitumomabFor imaging colorectal tumors
DB00117HistidineThe actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol.
DB00118AdemetionineS-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.
DB00120L-PhenylalanineL-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
DB00123L-LysineSupplemental L-lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
DB00125L-ArginineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00128L-Aspartic AcidThere is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
DB00130L-GlutamineUsed for nutritional supplementation, also for treating dietary shortage or imbalance. Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older [FDA Label].
DB00133SerineUsed as a natural moisturizing agent in some cosmetics and skin care products.
DB00134L-MethionineUsed for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.
DB00135L-TyrosineTyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.
DB00138CystineIt has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.
DB00142Glutamic AcidConsidered to be nature's "Brain food" by improving mental capacities; helps speed the healing of ulcers; gives a "lift" from fatigue; helps control alcoholism, schizophrenia and the craving for sugar.
DB00143GlutathioneFor nutritional supplementation, also for treating dietary shortage or imbalance
DB00145GlycineSupplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
DB00148CreatineFor nutritional supplementation, also for treating dietary shortage or imbalance
DB00149L-LeucineIndicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.
DB00150L-TryptophanTryptophan may be useful in increasing serotonin production, promoting healthy sleep, managing depression by enhancing mental and emotional well-being, managing pain tolerance, and managing weight.
DB00151L-CysteineFor the prevention of liver damage and kidney damage associated with overdoses of acetaminophen
DB00155L-CitrullineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00156L-ThreonineL-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation.
DB00160L-AlanineUsed for protein synthesis.
DB00161L-ValinePromotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria.
DB00167L-IsoleucineThe branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
DB00168AspartameUsed as a diet supplement and sugar substitute.
DB00172L-ProlineL-Proline is extremely important for the proper functioning of joints and tendons and also helps maintain and strengthen heart muscles.
DB00174L-AsparagineUsed for nutritional supplementation, also for treating dietary shortage or imbalance.
DB00177ValsartanMay be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Losartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.
DB00181BaclofenFor the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
DB00183PentagastrinUsed as a diagnostic aid for evaluation of gastric acid secretory function
DB00190CarbidopaFor treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonism
DB00230PregabalinPregabalin is used for the management of neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury, and postherpetic neuralgia. It is not approved for the management of fibromyalgia or as adjuntive therapy for adult partial onset seizures.[FDA label]
DB00260CycloserineUsed in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).
DB00279LiothyronineUsed as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.
DB00290BleomycinFor palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.
DB00314CapreomycinUsed in the treatment of tuberculosis in combination with other drugs.
DB00362AnidulafunginFor use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis), Aspergillus infections, and esophageal candidiasis. Also considered an alternative treatment for oropharyngeal canaidiasis.
DB00403CeruletideCaerulein stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. As such, it is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.
DB00420PromazineUsed as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
DB00451LevothyroxineFor use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.
DB00492FosinoprilFor treating mild to moderate hypertension, use as an adjunct in treating congestive heart failure, and may be used to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.
DB00509DextrothyroxineUsed to lower high cholesterol levels in the blood.
DB00512VancomycinFor the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci.
DB00513Aminocaproic AcidFor use in the treatment of excessive postoperative bleeding.
DB00520CaspofunginFor the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.
DB00556PerflutrenUsed as an ultrasound contrast imaging in cardiology and radiology.
DB00577ValaciclovirFor the treatment or suppression of cold sores (herpes labialis), herpes zoster (shingles), genital herpes in immunocompetent individuals, and recurrent genital herpes in HIV-infected individuals.
DB00584EnalaprilFor the treatment of essential or renovascular hypertension and symptomatic congestive heart failure. It may be used alone or in combination with thiazide diuretics.
DB00626BacitracinFor the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections. Used against gram positive bacteria. Bacitracin is also used as an inhibitor of proteases and other enzymes. However, specific activity of bactracin's inhibition of protein disulfide isomerase has been called into question.
DB00642PemetrexedUsed in combination with cisplatin for the treatment of malignant pleural mesothelioma in adults whose disease is unresectable or who otherwise are not candidates for potentially curative surgery. Also used as a monotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy
DB00644GonadorelinFor evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.
DB00666NafarelinFor treatment of central precocious puberty (true precocious puberty, GnRH-dependent precocious precocity, complete isosexual precocity) in children of both sexes and for the treatment of endometriosis.
DB00722LisinoprilFor the treatment of hypertension and symptomatic congestive heart failure. May be used in conjunction with thrombolytic agents, aspirin and/or β-blockers to improve survival in hemodynamically stable individuals following myocardial infarction. May be used to slow the progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
DB00731NateglinideFor the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise.
DB00765MetyrosineFor use in the treatment of patients with pheochromocytoma, for preoperative preparation of patients for surgery, management of patients when surgery is contraindicated, and chronic treatment of patients with malignant pheochromocytoma.
DB00775TirofibanFor treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.
DB00781Polymyxin B SulfateFor treatment of infections of the urinary tract, meninges, and blood stream, caused by susceptible strains of Pseudomonas aeruginosa.
DB00803ColistinFor the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
DB00837ProgabideIndicated for the treatment of epilepsy.
DB00855Aminolevulinic acidAminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
DB00859PenicillamineFor treatment of Wilson's disease, cystinuria and active rheumatoid arthritis.
DB00968MethyldopaFor use in the treatment of hypertension.
DB00970DactinomycinFor the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer as part of a combination chemotherapy and/or multi-modality treatment regimen
DB00992Methyl aminolevulinateFor topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).
DB00996GabapentinFor the management of postherpetic neuralgia in adults and as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy.
DB01042MelphalanFor the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. Has also been used alone or as part of various chemotherapeutic regimens as an adjunct to surgery in the treatment of breast cancer, alone or in combination regimens for palliative treatment of locally recurrent or unresectable in-transit metastatic melanoma of the extremities, as well as for the treatment of amyloidosis with prednisone.
DB01055MimosineNot Available
DB01072AtazanavirUsed in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.
DB01080VigabatrinFor use as an adjunct in treatment resistant epilepsy, refractory complex partial seizures, and secondary generalized seizures. It is also used as monotherapy in infantile spasms in West syndrome.
DB01111ColistimethateFor the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
DB01141MicafunginFor use in the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, as well as esophageal candidiasis, and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Micafungin is also used as an alternative for the treatment of oropharyngeal candidiases and has been used with some success as primary or salvage therapy, alone or in combination with other antifungals, for the treatment of invasive aspergillosis.
DB01197CaptoprilFor the treatment of essential or renovascular hypertension (usually administered with other drugs, particularly thiazide diuretics). May be used to treat congestive heart failure in combination with other drugs (e.g. cardiac glycosides, diuretics, β-adrenergic blockers). May improve survival in patients with left ventricular dysfunction following myocardial infarction. May be used to treat nephropathy, including diabetic nephropathy.
DB01221KetamineFor use as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation.
DB01229PaclitaxelUsed in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.
DB01235LevodopaFor the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.
DB01257EculizumabFor the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.
DB01269PanitumumabFor the treatment of EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens.
DB01270RanibizumabFor the treatment of patients with macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema.
DB01276ExenatideIndicated as adjunctive therapy to improve glycemic control in patients with Type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of both, but have not achieved adequate glycemic control.
DB01277MecaserminFor the long-term treatment of growth failure in pediatric patients with Primary IGFD or with GH gene deletion who have developed neutralizing antibodies to GH. It is not indicated to treat Secondary IGFD resulting from GH deficiency, malnutrition, hypothyroidism or other causes; it is not a substitute for GH therapy.
DB01278PramlintideFor the treatment of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
DB01279GalsulfaseFor the treatment of adults and children with Mucopolysaccharidosis VI.
DB01281AbataceptFor the management of the signs and symptoms of moderate-to-severe active rheumatoid arthritis, inducing major clinical response, slowing the progression of structural damage, and improving physical function in adult patients. It is indicated both as a monotherapy and for use in combination with a continued regimen of DMARDs (not including TNF antagonists). Also used for the management of the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in children.
DB01282CarbetocinUsed to control postpartum hemorrhage and bleeding after giving birth.
DB01284TetracosactideFor use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
DB01285CorticotropinFor use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
DB01306Insulin AspartFor the treatment of Type 1 or 2 diabetes mellitus. Should normally be used in conjunction with an intermediate or long-acting insulin.
DB01307Insulin DetemirFor the treatment of type 1 or 2 diabetes mellitus. May be used in combination with oral anti-diabetic agents in type 2 diabetic patients who are not in adequate metabolic control with oral anti-diabetic agents alone.
DB01309Insulin GlulisineFor the treatment of Type 1 and 2 diabetes mellitus. Should be used in regimens including a long-acting or basal insulin analogue unless it is used in a continuous infusion pump. May be used with oral antidiabetic agents.
DB01348SpiraprilSpirapril is an ACE inhibitor class drug used to treat hypertension.
DB01369QuinupristinFor the treatment of bacterial infections (usually in combination with dalfopristin).
DB01373CalciumCalcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. It is vital in cell signaling, muscular contractions, bone health, and signalling cascades.
DB01423SteproninStrepronin is a mucolytic (expectorant) drug.
DB01583LiotrixMay be used to treat primary, secondary or tertiary hypothyroidism. May also be used to suppress thyroid stimulating hormone (TSH) secretion in patients with simple (nontoxic) goiter, subacute or chronic lymphocytic thyroiditis multinodular goiter, and in the management of thyroid cancer. May be used in conjunction with other antithyroid agents to treat thyrotoxicosis to prevent goitrogenesis and hypothyroidism. May also be used for differential diagnosis of suspected mild hyperthyroidism or thyroid gland autonomy.
DB01584ThyroglobulinFor the treatment of hypothyroidism (deficiency in the production of thyroid hormone).
DB01646N-AcetylmethionineNot Available
DB01669Virginiamycin M1For the treatment of bacterial infections.
DB01683ChymostatinNot Available
DB01686N,N-dimethylarginineNot Available
DB01764DalfopristinFor the treatment of bacterial infections (usually in combination with quinupristin).
DB01783Pantothenic acidStudied for the treatment of many uses such as treatment of testicular torsion, diabetic ulceration, wound healing, acne, obesity, diabetic peripheral polyneuropathy. It has also been investigated for its hypolipidemic effects and as cholesterol lowering agent.
DB01853Bacteriochlorophyll ANot Available
DB02011N-(Phosphonoacetyl)-L-OrnithineNot Available
DB02083N,N-dimethylglycineNot Available
DB02109HadacidinNot Available
DB02123Glycochenodeoxycholic AcidNot Available
DB02137Molybdenum CofactorNot Available
DB02174D-GlutamineNot Available
DB02216S-MethylcysteineNot Available
DB02235L-methionine (R)-S-oxideNot Available
DB02236Glycinamide RibonucleotideNot Available
DB02255GM6001Not Available
DB02261Platelet Activating FactorNot Available
DB022747-Keto-8-Aminopelargonic AcidNot Available
DB02307N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-AsparagineNot Available
DB02341Mdl 101,146Not Available
DB02345SelenocysteineNot Available
DB02386Leucine Phosphonic AcidNot Available
DB02518N-AcetylalanineNot Available
DB02543Pyrrole-2-CarboxylateNot Available
DB02557PhosphoramidonNot Available
DB02578Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-AlanineNot Available
DB02595Bulgecin ANot Available
DB026014-HydroxyphenylglycineNot Available
DB02608N-Acetyl-P-NitrophenylserinolNot Available
DB02638TerlipressinCommonly used to stop bleeding of varices in the food pipe (oesophagus).
DB02655D-Aspartic AcidNot Available
DB02810N-(2-Acetamido)Iminodiacetic AcidNot Available
DB02821CanalineNot Available
DB02855N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineNot Available
DB02952Alpha-Aminoisobutyric AcidNot Available
DB02959OxitriptanFor use as an antidepressant, appetite suppressant, and sleep aid.
DB02975GE-2270ANot Available
DB02978Beta-HydroxyleucineNot Available
DB02999QuisqualateNot Available
DB03032S-OctylglutathioneNot Available
DB03088Pidolic AcidNot Available
DB03107Beta-AlanineNot Available
DB03144N-Omega-Hydroxy-L-ArginineNot Available
DB03157N,O-Didansyl-L-TyrosineNot Available
DB03214VinylglycineNot Available
DB03223DiphthamideNot Available
DB03251RWJ-51084Not Available
DB03295GlutathionylspermidineNot Available
DB03360N-AcetylprolineNot Available
DB03380L-TyrosinamideNot Available
DB03395EnalkirenNot Available
DB03408gamma-GlutamylcysteineNot Available
DB03424UbenimexAn adjuvant therapy used for acute and chronic myelonous leukemia, lung cancer and nasopharyngeal cancer. It is also used to treat hypercholesterolaemia.
DB034252s,4r-4-MethylglutamateNot Available
DB03436GallichromeNot Available
DB03458N(4)-adenosyl-N(4)-methyl-2,4-diaminobutanoic acidNot Available
DB03459Sparfosic acidNot Available
DB03470TrypanothioneNot Available
DB03535Z-Pro-ProlinalNot Available
DB03544S-PhosphocysteineNot Available
DB035523-TyrosineNot Available
DB03632ArgifinNot Available
DB03640Beta-Hydroxyaspartic AcidNot Available
DB036604-Iodo-L-phenylalanineNot Available
DB03709BicineNot Available
DB03799TrifluoromethionineNot Available
DB038172,4-Diaminobutyric AcidNot Available
DB03880BatimastatNot Available
DB03889S-(N-Hydroxy-N-Bromophenylcarbamoyl)GlutathioneNot Available
DB03940Oxamic AcidNot Available
DB04029Phenylalanine AmideNot Available
DB04092ApstatinNot Available
DB04111BalhimycinNot Available
DB04129WillardiineNot Available
DB04132S-HexylglutathioneNot Available
DB04167AceglutamideNot Available
DB04185NorvalineNot Available
DB04189N2-(Carboxyethyl)-L-ArginineNot Available
DB04191Skf 107457Not Available
DB04217L-2-amino-3-butynoic acidNot Available
DB04223NitroarginineNot Available
DB04269Cyclotheonamide ANot Available
DB04284L-proline betaineNot Available
DB04291OxfenicineNot Available
DB04308D-4-hydroxyphenylglycineNot Available
DB043346-hydroxydopa quinoneNot Available
DB04339CarbocisteineUsed to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis.
DB04350ArgadinNot Available
DB04370S-sulphocysteineNot Available
DB04383L-ValinolNot Available
DB04391Aeruginosin 98-BNot Available
DB04418Adenylosuccinic AcidNot Available
DB044363-FluorotyrosineNot Available
DB04454Alpha-Aminobutyric AcidNot Available
DB04464N-FormylmethionineNot Available
DB04495RU81843Not Available
DB04498Aspartate SemialdehydeNot Available
DB04527Beta-HydroxyasparagineNot Available
DB04539GlyphosateNot Available
DB04584PhenyldehydroalanineNot Available
DB04620CycloleucineNot Available
DB04676DansyllysineNot Available
DB04738MotuporinNot Available
DB04798THIO-ATPANot Available
DB04805Virginiamycin S1Not Available
DB04847RoxadustatIn clinical development for the treatment of anemia of chronic inflammatory disease.
DB04869OlcegepantFor the treatment of migraine headaches.
DB04894VapreotideFor the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.
DB04897LucinactantIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
DB04899NesiritideFor the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
DB04900ThymalfasinIndicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate antibody titers from previous immunization.
DB04901GaliximabInvestigated for use/treatment in lymphoma (non-hodgkin's), psoriasis and psoriatic disorders, bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.
DB04911OritavancinInvestigated for use/treatment in bacterial infection and skin infections/disorders.
DB04914G17DTIntended for the treatment of various forms of cancer.
DB04921DirucotideFor the treatment of multiple sclerosis (MS).
DB04925DesmoteplaseInvestigated for use/treatment in cerebral ischemia and strokes.
DB04931AfamelanotideInvestigated for use/treatment in actinic keratosis, keratoses, skin cell studies, and skin infections/disorders.
DB04949PexelizumabFor the treatment of inflammation during cardiac surgery.
DB04952RamoplaninFor the treatment of bacterial infections.
DB04956AfelimomabInvestigated for use/treatment in sepsis and septicemia.
DB04958EpratuzumabInvestigated for use/treatment in leukemia (lymphoid), lymphoma (non-hodgkin's), and systemic lupus erythematosus.
DB04962BectumomabInvestigated for use/treatment in lymphoma (non-hodgkin's).
DB04964OregovomabInvestigated for use/treatment in ovarian cancer.
DB04972CanfosfamideIntended for the treatment of various forms of cancer.
DB04977PlitidepsinIntended for the treatment of various forms of cancer.
DB04985TigapotideFor the treatment of late stage Hormone Refractory Prostate Cancer (HRPC) for which no effective therapy currently exists.
DB04988IGN311Intended for the treatment of various forms of cancer.
DB05006AdecatumumabInvestigated for use/treatment in breast cancer and prostate cancer.
DB05012XEN2174For the treatment of chronic cancer pain.
DB05029LancovutideInvestigated for use/treatment in cystic fibrosis and eye disorders/infections.
DB05031XP19986Investigated for use/treatment in gastroesophageal reflux disease (GERD).
DB05032REV131Investigated for use/treatment in allergic reaction, allergic rhinitis, and cataracts.
DB05034UlaritideInvestigated for use/treatment in congestive heart failure.
DB05084AbaloparatideInvestigated for use/treatment in postmenopausal osteoporosis to reduce vertebral and/or non-vertebral fractures.
DB05092CDP323Investigated for use/treatment in multiple sclerosis.
DB05096LY2140023Investigated for use/treatment in psychosis and schizophrenia and schizoaffective disorders.
DB05097LabetuzumabLabetuzumab is a humanized monoclonal antibody used to treat cancer. Retrieved from "http://en.wikipedia.org/wiki/Labetuzumab"
DB05098LeptinInvestigated for use/treatment in lipodystrophy and obesity.
DB05101MatuzumabInvestigated for use/treatment in cervical dysplasia/cancer, colorectal cancer, gastric cancer, and lung cancer.
DB05111FontolizumabInvestigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.
DB05115NN344Investigated for use/treatment in diabetes mellitus type 1 and 2.
DB05128AminocandinInvestigated for use/treatment in fungal infections.
DB05130INCB3284Investigated for use/treatment in inflammatory disorders (unspecified).
DB05136BavituximabInvestigated for use/treatment in breast cancer, cancer/tumors (unspecified), HIV infection, hepatitis (viral, C), and solid tumors.
DB05139CR002Investigated for use/treatment in nephropathy.
DB05155CR665Investigated for use/treatment in pain (acute or chronic).
DB05158PM02734Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
DB05160TopsalysinInvestigated for use/treatment in benign prostatic hyperplasia, cancer/tumors (unspecified), prostate cancer, prostate disorders, and solid tumors.
DB05161ElafinInvestigated for use/treatment in inflammatory disorders (unspecified).
DB05199LX1031Irritable bowel syndrome (IBS) and other gastrointestinal disorders
DB05209SYM001Investigated for use/treatment in thrombocytopenia.
DB05210SF1126For the treatment of various forms of cancer.
DB05258Natural alpha interferonInvestigated for use/treatment in hepatitis (viral, C), leukemia (lymphoid), leukemia (myeloid), leukemia (unspecified), and melanoma.
DB05259Glatiramer AcetateFor reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.
DB05276Hepatitis B Immune GlobulinInvestigated for use/treatment in hepatitis (viral, B), liver transplant surgery, and pediatric indications.
DB05299keyhole limpet hemocyaninInvestigated for use/treatment in bladder cancer and solid tumors.
DB05305Cintredekin BesudotoxInvestigated for use/treatment in brain cancer.
DB05311EcallantideFor the treatment of angioedema.
DB05319oportuzumab monatoxInvestigated for use/treatment in bladder cancer and head and neck cancer.
DB05332RomiplostimTreatment of chronic immune thrombocytopenic purpura.
DB05336ObiltoxaximabInvestigated for use/treatment in anthrax exposure, bacterial infection, crohn's disease, and graft versus host disease.
DB05344Ciliary neurotrophic factorInvestigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).
DB05365BF-200 ALAInvestigated for use/treatment in actinic keratosis.
DB05393NOV-002Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer.
DB05394CorticorelinInvestigated for use/treatment in brain cancer and neurologic disorders.
DB05396Albinterferon Alfa-2BInvestigated for use/treatment in hepatitis (viral, C).
DB05405XTL-001Investigated for use/treatment in hepatitis (viral, B).
DB05413TifuvirtideInvestigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.
DB05434ABT-510Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.
DB05437RIGScan CR49Investigated for use/treatment in colorectal cancer and solid tumors.
DB05446LJP 1082Investigated for use/treatment in autoimmune diseases, strokes, and thrombosis.
DB05459BriakinumabInvestigated for use/treatment in autoimmune diseases, crohn's disease, multiple sclerosis, psoriasis and psoriatic disorders, and rheumatoid arthritis.
DB05460EzatiostatInvestigated for use/treatment in myelodysplastic syndrome.
DB05475GolotimodInvestigated for use/treatment in hepatitis (viral, C), infectious and parasitic disease (unspecified), and tuberculosis.
DB05476WX-UK1Investigated for use/treatment in solid tumors.
DB05496OtelixizumabInvestigated for use/treatment in diabetes mellitus type 1, pediatric indications, and psoriasis and psoriatic disorders.
DB05507VX-765Investigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders.
DB05521TelaprevirTelaprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults [FDA Label].
DB05578RamucirumabFor use in advanced gastric or gastro-esophageal junction adenocarcinoma as a single agent or in combination with paclitaxel after prior fluoropyrimidine- or platinum-containing chemotherapy.
DB05595FarletuzumabInvestigated for use/treatment in ovarian cancer.
DB05675EP-2104RInvestigated for use/treatment in cardiovascular disorders and thrombosis.
DB05679UstekinumabUstekinumab is indicated for management of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy; or is used alone or in conjunction with methotrexate for the management of active psoriatic arthritis in adults. The FDA approved the use of ustekinumab in September 2016 for the treatment of moderate to severe Crohn's disease. The use of ustekinumab may improve short term clinical response but not clinical remission in moderate to severe Crohn's disease.
DB05687BL-1020Investigated for use/treatment in schizophrenia and schizoaffective disorders.
DB05713LY-517717Investigated for use/treatment in thrombosis and venous thromboembolism.
DB05718Maxy-G34Investigated for use/treatment in adverse effects (chemotherapy) and neutropenics.
DB05739CYT006-AngQbInvestigated for use/treatment in hypertension.
DB05773Trastuzumab emtansineUsed in HER2-positive, metastatic breast cancer patients who have already used taxane and/or trastuzumab for metastatic disease or had their cancer recur within 6 months of adjuvant treatment.
DB05777Thrombomodulin AlfaInvestigated for use/treatment in blood preservative, blood (blood forming organ disorders, unspecified), sepsis and septicemia, and thrombosis.
DB05779OglufanideInvestigated for use/treatment in hepatitis (viral, C).
DB05793PRO-542Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications.
DB05797TNX-901Investigated for use/treatment in allergic reaction.
DB05819NBI-6024Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
DB05829Parathyroid hormoneFor use/treatment in osteoporosis.
DB05833lymphotoxin beta receptorInvestigated for use/treatment in autoimmune diseases.
DB05864PPI-2458Investigated for use/treatment in lymphoma (non-hodgkin's) and solid tumors.
DB05875substance PInvestigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
DB05889Inotuzumab ozogamicinIndicated as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL).
DB05892RI 624Investigated for use/treatment in pain (acute or chronic).
DB05915MYO-029Investigated for use/treatment in muscular dystrophy.
DB06043OlaratumabOlaratumab is indicated, in combination with doxorubicin, for the treatment of adult patients with advanced or mestastatic soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery.
DB06101IMC-1C11Investigated for use/treatment in cancer/tumors (unspecified).
DB06149TeicoplaninFor the treatment of bacterial infections caused by susceptible microorganisms.
DB06151AcetylcysteineAcetylcysteine is used mainly as a mucolytic and in the management of paracetamol (acetaminophen) overdose.
DB06168CanakinumabUsed in patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated Periodic Syndromes (CAPS) as well as for patients 2 years of age and older to treat systemic juvenile idiopathic arthritis (SJIA).
DB06176RomidepsinFor the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been demonstrated.
DB06186IpilimumabIpilimumab is indicated for the treatment of unresectable or metastatic melanoma in adults. It is also used to reduce the risk of the deadly skin cancer returning after surgery.
DB06196IcatibantApproved for use in acute attacks of hereditary angioedema (HAE). Investigated for use/treatment in angioedema, liver disease, and burns and burn infections.
DB06219DalbavancinDalbavancin is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains), S. pyogenes, S. agalactiae, and S. anginosus group (including S. anginosus, S. intermedius, and S. constellatus). It is administered as a 30 minute IV infusion in a two-dose regimen of 1000 mg followed by 500 mg one week later.
DB06243EflornithineEflornithine is indicated in the treatment of facial hirsutism (excessive hair growth).
DB06261HexaminolevulinateHexaminolevulinate is indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy.
DB06262DroxidopaFor treatment of neurogenic orthostatic hypotension (NOH) associated with various disorders including Multiple System Atrophy, Familial Amyloid Polyneuropathy, hemodialysis induced hypotension and Parkinson's Disease. Also investigated for use/treatment in neurologic disorders, nephropathy, blood (blood forming organ disorders, unspecified), and dizzy/fainting spells.
DB06273TocilizumabIndicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs). It is also indicated for the treatment of active polyarticular juvenile idiopathic arthritis (PJIA) and active systemic juvenile idiopathic arthritis (SJIA) in patients 2 years of age and older.
DB06285TeriparatideFor the treatment of osteoporosis in men and postmenopausal women who are at high risk for having a fracture. Also used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.
DB06317ElotuzumabIndicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.
DB06335SaxagliptinTreatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy.
DB06366PertuzumabPertuzumab is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
DB06372RilonaceptRilonacept is currently used in the treatment of cryopyrin-associated periodic syndrome. In May 2012, an advisory panel for the FDA voted 11-0 against the use of Rilonacept for the treatment of gout.
DB06404Human C1-esterase inhibitorFor routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).
DB06602ReslizumabInvestigated for use/treatment in esophageal disorders and pediatric indications.
DB06612MepolizumabMepolizumab is indicated for add-on maintenance treatment of severe eosinophilic asthma, as identified by blood eosinophils greater than or equal to 150 cells/μl at initiation of treatment or blood eosinophils greater than or equal to 300 cells/μl in the past 12 months, in patients aged 12 years and older. Mepolizumab has been shown to reduce exacerbations of asthma in patients with an exacerbation history
DB06643DenosumabProlia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. It reduces the incidence of vertebral, nonvertebral, and hip fractures. Prolia is also indicated as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. It can also be used in men with osteoporosis at high risk for fracture or in men receiving androgen deprivation therapy for nonmetastatic prostate cancer to increase bone mass. Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors.
DB06650OfatumumabOfatumumab is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and alemtuzumab.
DB06654SafinamideSafinamide is indicated as an add-on treatment to levodopa with or without other medicines for Parkinson’s disease
DB06655LiraglutideFor use in/treatment of diabetes mellitus type 2.
DB06663PasireotideFor the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery has not been curative or is not an option.
DB06674GolimumabUsed in adults (i) as an adjunct to methotrexate treatment in patients with moderate to severe active rheumatoid arthritis (RA), (ii) alone or as an adjunct to methotrexate treatment in patients with active psoriatic arthritis (PsA), (iii) as a single agent in patients with active ankylosing spondylitis (AS), and (iv) as a single agent in patients with moderate to severe ulcerative colitis (UC) who require chronic steroids or have experienced intolerance or only a partial response to previous medications.
DB06681BelataceptFor prophylaxis of organ rejection. It is also used concomitantly with basiliximumab for induction therapy, mycophenolate, and corticosteriods in kidney transplant recepients that are seropositive for the Epstein-Barr virus.
DB06692AprotininFor prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.
DB06699DegarelixDegaralix is used for the management of advanced prostate cancer.
DB06719BuserelinBuserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
DB06775Carglumic AcidFor the treatment of acute and chronic hyperammonaemia in patients with N-acetylglutamate synthase (NAGS) deficiency. This enzyme is an important component of the urea cycle to prevent build up of neurotoxic ammonium in the blood.
DB06785GanirelixFor the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
DB06788HistrelinAs the product Supprelin LA (FDA), histrelin is indicated for the treatment of children with central precocious puberty (CPP). As the product Vantas (FDA), histrelin is indicated for the palliative treatment of advanced prostate cancer.
DB06791LanreotideLanreotide is a somatostatin analog approved for treatment of neuroendocrine tumours and acromegaly. (2)
DB06794LodoxamideIndicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
DB06823TioproninTiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.
DB06825TriptorelinTriptorelin is indicated for the palliative treatment of advanced prostate cancer.
DB06827ViomycinViomycin is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis.
DB07744Z-Val-Ala-Asp fluoromethyl ketoneNot Available
DB08508N-BENZOYL-D-ALANINENot Available
DB08626ThiorphanNot Available
DB08847HydroxyprolineUsed in France as a combination product for the treatment of small, superficial wounds.
DB08862CholecystokininFor use as a diagnostic aid for evaluation of gallbladder disorders.
DB08869TesamorelinTesamorelin acetate is a synthetic analogue of human hypothalamic Growth Hormone Releasing Factor (hGRF) indicated to induce and maintain a reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.
DB08870Brentuximab vedotinUsed in the treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
DB08872Gabapentin EnacarbilFor the treatment of adult Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
DB08873BoceprevirBoceprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults [FDA Label].
DB08879BelimumabAdjunct treatment for auto-antibody-positive active systemic lupus erythematosus.
DB08885AfliberceptThe opthalmic agent is used for the treatment of neovascular (wet) age-related mascular degeneration (AMD) and macular edema following central retinal vein occulsion (CRVO). The systemic injection, known as ziv-aflibercept, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is for the treatment of metastatic colorectal cancer that is resistant to or progressed following treatment with oxaliplatin.
DB08888OcriplasminOcriplasmin is a proteolytic enzyme indicated for the treatment for symptomatic vitreomacular adhesion.
DB08889CarfilzomibCarfilzomib is indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy. Approval is based on response rate.
DB08890LinaclotideTreatment of irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation.
DB08892Arbaclofen PlacarbilInvestigated for the treatment of spasticity in multiple sclerosis, acute back spasms, and GERD.
DB08894PeginesatidePeginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis
DB08900TeduglutideTreatment of short bowel syndrome (SBS), malabsorption associated with the removal of the intestine, in adults patients who are dependent on parenteral support.
DB08902RaxibacumabRaxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
DB08904Certolizumab pegolReducing signs and symptoms of Crohn's disease and treatment of moderately to severely active rheumatoid arthritis (RA).
DB08935ObinutuzumabObinutuzumab is used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia.
DB08993EnviomycinNot Available
DB09029SecukinumabFor the treatment of moderate to severe plaque psoriasis in patients that are candidates for systemic therapy or phototherapy.
DB09033VedolizumabVedolizumab is indicated for adult patients with moderately to severely active UC or CD who have had an inadequate response with, lost response to, or were intolerant to a tumor necrosis factor (TNF) blocker or immunomodulator; or had an inadequate response with, were intolerant to, or demonstrated dependence on corticosteroids.
DB09035NivolumabNivolumab is indicated for the treatment of unresectable or metastatic melanoma for patients who no longer respond to treatment with other drugs. It is intended for use in patients who have been previously treated with ipilimumab and is used for melanoma patients after treatment with ipilimumab and a BRAF inhibitor in patients whose tumors express BRAF V600 gene mutations. Historically there have been very few effective treatments for advanced melanoma, which is why this product was approved under an FDA accelerated program to allow earlier patient access.
DB09036SiltuximabSiltuximab is indicated for the treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative. Siltuximab did not bind to virally produced IL-6 in a nonclinical study and was therefore not studied in patients with MCD who are HIV or HHV-8 positive.
DB09037PembrolizumabPembrolizumab is a programmed death receptor-1 (PD-1)-blocking antibody indicated for the treatment of:  patients with unresectable or metastatic melanoma.  patients with metastatic NSCLC whose tumors have high PD-L1 expression [(Tumor Proportion Score (TPS) ≥50%)] as determined by an FDA-approved test, with no EGFR or ALK genomic tumor aberrations, and no prior systemic chemotherapy treatment for metastatic NSCLC.  patients with metastatic NSCLC whose tumors express PD-L1 (TPS ≥1%) as determined by an FDA-approved test, with disease progression on or after platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving KEYTRUDA.  patients with recurrent or metastatic HNSCC with disease progression on or after platinum-containing chemotherapy. This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials.
DB09043AlbiglutideIndicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
DB09045DulaglutideIndicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
DB09046MetreleptinMetreleptin is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
DB09052BlinatumomabIndicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
DB09067Corticorelin ovine triflutateCorticorelin is indicated for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
DB09077DinutuximabDinutuximab is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy. Despite a high clinical response seen after first-line treatment, the complete eradication of neuroblastoma is rarely achieved and the majority of patients with advanced disease suffer a relapse. Current strategies for treatment include immunotherapy with drugs such as dinutuximab to target surviving neuroblastoma cells and to prevent relapse.
DB09098SomatremNot Available
DB09099SomatostatinFor the symptomatic treatment of acute bleeding from esophageal varices. Other treatment options for long-term management of the condition may be considered if necessary, once initial control has been established.
DB09103AncestimNot Available
DB09105Asfotase AlfaIndicated for the treatment of patients with perinatal/infantile and juvenile onset hypophosphatasia (HPP).
DB09107Methoxy polyethylene glycol-epoetin betaFor the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required.
DB09109Turoctocog alfaNot Available
DB09122Peginterferon beta-1aFor the treatment of patients with relapsing forms of multiple sclerosis.
DB09126Chorionic Gonadotropin (Human)For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.
DB09137Technetium Tc-99m mebrofeninTechnetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
DB09141Protamine sulfateProtamine sulfate is usually administered to reverse the large dose of heparin administered during certain surgeries, especially heart surgery.
DB09142SincalideAs the product Kinevac (FDA), sincalide is used for the following indications: 1) to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; (2) to stimulate pancreatic secretion (especially in conjunction with secretin) prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; (3) to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.
DB09164Technetium Tc-99m disofeninTechnetium Tc99m Disofenin is indicated as a hepatobiliary imaging agent. Hepatolite is indicated in the diagnosis of acute cholecystitis as well as to rule out the occurrence of acute cholecystitis in suspected patients with right upper quadrant pain, fever, jaundice, right upper quadrant tenderness and mass or rebound tenderness, but not limited to these signs and symptoms.
DB09221PolaprezincNot Available
DB09222Fibrinogen HumanFor the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.
DB09230AzelnidipineFor the treatment of hypertension.
DB09264IdarucizumabFor use in patients treated with Dabigatran when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.
DB09265LixisenatideFor use as an antihyperglycemic agent in the treatment of T2DM [FDA Label].
DB09272EluxadolineFor the treatment of irritable bowel syndrome with diarrhea (IBS-D).
DB09292SacubitrilUsed in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB.
DB09302AlirocumabAlirocumab is indicated as an adjunct to diet and maximally tolerated statin therapy in adults who require additional LDL-cholesterol (LDL-C) lowering due to heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease.
DB09303EvolocumabFor the treatment of heterozygous/homozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients on maximum tolerated statin therapy requiring additional LDL-cholesterol lowering.
DB09312Antilymphocyte immunoglobulin (horse)For prevention of renal transplant rejection and for the treatment of aplastic anemia.
DB09331DaratumumabFor the treatment of patients with multiple myeloma who have received at least three prior lines of therapy (a proteasome inhibitor (PI) and an immunomodulatory agent) or who are double-refractory to a PI and an immunomodulatory agent. This indication was approved by accelerated approval based on response rate.
DB09349Gastric intrinsic factorIntrinsic factor is not currently available in any FDA or Health Canada approved products. However, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic Vitamin B12), ferrous fumarate, and ascorbic acid for the treatment of anemias responsive to oral iron therapy.
DB09357DexpanthenolInjection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus. Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).
DB09421ProtirelinNot Available
DB09477EnalaprilatEnalaprilat injection is indicated for the treatment of hypertension when oral therapy is not practical.
DB09559NecitumumabNecitumumab is approved for use in combination with cisplatin and gemcitabine as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC). It is not indicated for treatment of non-squamous NSCLC.
DB09564Insulin DegludecInsulin degludec is indicated to improve glycemic control in adults with diabetes mellitus.
DB09570IxazomibIxazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
DB10516CaseinNot Available
DB10789Bordetella pertussis pertactin antigenNot Available
DB11091Hydrogen peroxideNot Available
DB11095DesirudinIndicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
DB11102N-acetyltyrosineNot Available
DB11142SelenomethionineNot Available
DB11210Ferrous bisglycinateNot Available
DB11242GelatinNot Available
DB11256Levomefolic acidFor the treatment and prevention of folate deficiency and for use as an antidote against folic acid antagonists. Contained in oral contraceptives to reduce the risk of neural tube defects arising from folic acid deficiency for pregnant women who conceived during use or shortly after the discontinuation of the product. Being studied for use as a treatment for cardiovascular diseases [A19273] and adjunct therapy for patients undergoing antidepressant pharmacotherapy [A19271, A19272].
DB11296PrezatideCommonly used in cosmetic products for the skin and hair [A19503].
DB11298ThioredoxinNot Available
DB11300ThrombinNot Available
DB11311ProthrombinFor use in the emergency reversal of coagulation factor deficiency in patients receiving vitamin K antagonist therapy. Prothrombin is administered as part of a cocktail containing several coagulation factors.
DB11312Protein CNot Available
DB11330Factor IX Complex (Human)Factor IX Complex is indicated for the prevention and control of hemorrhagic episodes in hemophilia B patients. It is also indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or who require rapid reversal of therapy.
DB11364PidotimodFor use as immunostimulant therapy for treatment of cell-mediated immunosuppression with respiratory or urinary infections [L929].
DB11569Ixekizumab Ixekizumab is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
DB11595AtezolizumabFor the treatment of patients with locally advanced or metastatic urothelial carcinoma who: 1) have disease progression during or following platinum-containing chemotherapy, and 2) have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
DB11598Antithrombin III humanAntithrombin III human is a human antithrombin (AT) indicated in patients with hereditary antithrombin deficiency for the treatment and prevention of thromboembolism and prevention of peri-operative and peri-partum thromboembolism
DB11611LifitegrastFor the treatment of signs and symptoms of keratoconjunctivitis sicca (dry eye syndrome).
DB11621Human Varicella-Zoster Immune GlobulinIndicated for preventing and reducing the severity of chicken pox (varicella zoster virus) infections in high risk individuals within 4 days of exposure to varicella zoster virus.
DB11646ConatumumabNot Available
DB11653BremelanotideNot Available
DB11656RebamipideNot Available
DB11657TabalumabNot Available
DB11668Rusalatide acetateNot Available
DB11680FiclatuzumabNot Available
DB11682DaprodustatNot Available
DB11685FigitumumabNot Available
DB11690VonapanitaseNot Available
DB11695CarnosineNot Available
DB11696RacecadotrilNot Available
DB11700SetmelanotideNot Available
DB11706RaxatrigineNot Available
DB11709Acetyl hexapeptide-8Not Available
DB11714DurvalumabDurvalumab is indicated for patients with urothelial carcinoma, such as urinary bladder, urethra or ureter cancer. Patients with prolonged disease progression due to failed platinum-based chemotherapy such as cisplatin and carboplatin are most likely to benefit from durvalumab treatment. Its clinical effectiveness is especially enhanced in PD-L1-positive patient groups [A19123].
DB11715BapineuzumabNot Available
DB11724BombesinNot Available
DB11746OnartuzumabNot Available
DB11756SolanezumabNot Available
DB11767SarilumabIndicated for modere to severe reactive RA in adult patients who are irresponsive, respond inadequately or present intolerance to disease-modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. It is indicated to be used in combination with methotrexate (MTX) or as a monotherapy when there is intolerance to MTX or MTX administration is inappropriate.
DB11771TremelimumabNot Available
DB11776BrodalumabBrodalumab has been approved for the treatment of psoriasis vulgaris, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma.
DB11777CenderitideNot Available
DB11781TosedostatNot Available
DB11782BirinapantNot Available
DB11788Neuropeptide YNot Available
DB11803SirukumabNot Available
DB11808FaldaprevirNot Available
DB11815TilarginineNot Available
DB11821DanegaptideNot Available
DB11826LampalizumabNot Available
DB11834GuselkumabIndicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
DB11840DalotuzumabNot Available
DB11842Angiotensin IiNot Available
DB11849EmibetuzumabNot Available
DB11854AstodrimerNot Available
DB11856LigelizumabNot Available
DB11857SeribantumabNot Available
DB11862LandogrozumabNot Available
DB11865Brivanib alaninateNot Available
DB11866RomosozumabNot Available
DB11869ValspodarNot Available
DB11876Alanyl GlutamineNot Available
DB11882BPC-157Not Available
DB11895GhrelinNot Available
DB11906AcylineNot Available
DB11915ValbenazineFor the treatment of tardive dyskinesia in adults [FDA Label].
DB11928VosoritideNot Available
DB11945AvelumabIndicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC).
DB11955AvoterminNot Available
DB11956DelanzomibNot Available
DB11958BrivanibNot Available
DB11959CrenezumabNot Available
DB11972RilotumumabNot Available
DB11975TAK-448Not Available
DB11976AnifrolumabNot Available
DB11981ElamipretideNot Available
DB11988OcrelizumabOcrelizumab is indicated for the treatment of adult patients with relapsing or primary progressive forms of multiple sclerosis.
DB11991OprozomibNot Available
DB11997Interleukin-7Not Available
DB12003Thymosin beta-4Not Available
DB12005NirogacestatNot Available
DB12023BenralizumabNot Available
DB12034GantenerumabNot Available
DB12038UlinastatinNot Available
DB12042IbodutantNot Available
DB12044MK-0893Not Available
DB12053VisilizumabNot Available
DB12054BQ-123Not Available
DB12056TrebananibNot Available
DB12075NagrestipenNot Available
DB12076SurotomycinNot Available
DB12088TT-232Not Available
DB12089Lorvotuzumab mertansineNot Available
DB12090PatritumabNot Available
DB12095TelotristatAs a serotonin synthesis inhibitor, telotristat etiprate, has the potential to reduce serotonin levels and address the key elements of carcinoid syndrome.
DB12099UK-396,082Not Available
DB12102FulranumabNot Available
DB12104TarextumabNot Available
DB12105ImagabalinNot Available
DB12118SotaterceptNot Available
DB12119GevokizumabNot Available
DB12126BradykininNot Available
DB12132Vanutide cridificarNot Available
DB12139AlisporivirNot Available
DB12142DuligotuzumabNot Available
DB12146RigosertibNot Available
DB12159DupilumabDupilumab is a monoclonal antibody designed for the treatment of atopic diseases such as eczema.
DB12160BucillamineNot Available
DB12169TralokinumabNot Available
DB12182BinetrakinNot Available
DB12189EtrolizumabNot Available
DB12205GanitumabNot Available
DB12213EtaracizumabNot Available
DB12224Oxothiazolidinecarboxylic acidNot Available
DB12240Polatuzumab VedotinNot Available
DB12246InclacumabNot Available
DB12250CixutumumabNot Available
DB12261AscrinvacumabNot Available
DB12271ORE-1001Not Available
DB12274AducanumabNot Available
DB12279OBP-801Not Available
DB12292BarusibanNot Available
DB12304EntolimodNot Available
DB12330BlisibimodNot Available
DB12335TanezumabNot Available
DB12349DulanerminNot Available
DB12363DusigitumabNot Available
DB12370IpamorelinNot Available
DB12373IsunakinraNot Available
DB12396FresolimumabNot Available
DB12409Vatreptacog alfaNot Available
DB12431MuplestimNot Available
DB12444TheanineNot Available
DB12451SCY-635Not Available
DB12456BococizumabNot Available
DB12460ConberceptNot Available
DB12463SemagacestatNot Available
DB12486ElobixibatNot Available
DB12489Mirvetuximab SoravtansineNot Available
DB12490ForigerimodNot Available
DB12493PD-217014Not Available
DB12495SelepressinNot Available
DB12498MogamulizumabNot Available
DB12514Iofolastat I-123Not Available
DB12519SarcosineNot Available
DB12525MolgramostimNot Available
DB12530InebilizumabNot Available
DB12534MavrilimumabNot Available
DB12538NepadutantNot Available
DB12560BlosozumabNot Available
DB12566DecernotinibNot Available
DB12568TecemotideNot Available
DB12584BimagrumabNot Available
DB12589DacetuzumabNot Available
DB12602PentetreotideNot Available
DB12609TovetumabNot Available
DB12613DavunetideNot Available
DB12616SpriferminNot Available
DB12620Nerve Growth FactorNot Available
DB126293,5-diiodothyropropionic acidNot Available
DB12648Nona-arginineNot Available
DB12652Endothelin-1Not Available
DB12677SoblidotinNot Available
DB12678RelamorelinNot Available
DB12684AviscumineNot Available
DB12697MethylselenocysteineNot Available
DB12698IbalizumabNot Available
DB12699BalugrastimNot Available
DB12701IntetumumabNot Available
DB12711LTX-109Not Available
DB12718CarlumabNot Available
DB12726MonteplaseNot Available
DB12730Dolastatin 10Not Available
DB12732FirategrastNot Available
DB12734DemcizumabNot Available
DB12738TiplimotideNot Available
DB12748LTX-315Not Available
DB12750N-omega-nitro-L-arginine methyl esterNot Available
DB12755Zoptarelin doxorubicinNot Available
DB12762RabacfosadineNot Available
DB12775AbituzumabNot Available
DB12777SomatoprimNot Available
DB12795CMX-2043Not Available
DB12807Naptumomab EstafenatoxNot Available
DB12815CrotedumabNot Available
DB12820ConcizumabNot Available
DB12822Pancreatic PolypeptideNot Available
DB12826DepatuxizumabNot Available
DB12827IndoximodNot Available
DB12835Olipudase alfaNot Available
DB12844RontalizumabNot Available
DB12845AmatuximabNot Available
DB12849ClazakizumabNot Available
DB12863SivelestatNot Available
DB12865EtelcalcetideEtelcalcetide is a calcium-sensing receptor agonist indicated for: Secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
DB12870Buthionine SulfoximineNot Available
DB12876GS-9256Not Available
DB12878AV-101Not Available
DB12880Interleukin-10Not Available
DB12882OmbrabulinNot Available
DB12891OzanezumabNot Available
DB12893Sacituzumab govitecanNot Available
DB12909Factor XIII (human)Not Available
DB12938IsoxaflutoleNot Available
DB12943MilatuzumabNot Available
DB12951PivagabineNot Available
DB12976RobatumumabNot Available
DB12992Bleomycin A6Not Available
DB13006CibinetideNot Available
DB13033Urocortin-2Not Available
DB13045RacotumomabNot Available
DB13067RotigaptideNot Available
DB130689-(N-methyl-L-isoleucine)-cyclosporin ANot Available
DB13074MacimorelinNot Available
DB13091TiropramideNot Available
DB13127OlokizumabNot Available
DB13133Von Willebrand Factor HumanNot Available
DB13144LenograstimThe drug is used to reduce the risk of life-threatening infection in patients with neutropenia, particularly after cytotoxic chemotherapy. Lenograstim is indicated as a treatment to reduce the duration of neutropenia and the severity of infections in patients with non-myeloid malignancy who have undergone autologous or allogeneic bone marrow transplantation, or treatment with established cytotoxic chemotherapy and in addition to reduce the incidence of infection associated with established cytotoxic chemotherapy. Lenograstim is also indicated to mobilise peripheral blood progenitor cells (PBPCs) with Lenograstim alone, or after myelosuppressive chemotherapy, in order to accelerate haematopoietic recovery by infusion of such cells, after myelosuppressive or myeloablative therapy. Lenograstim is also indicated to accelerate the engraftment of these cells after their reinfusion. GRANOCYTE is also indicated for the treatment of severe chronic neutropenia including congenital agranulocytosis (Kostmann's syndrome).
DB13146FluciclovineAxumin is indicated for positron emission tomography (PET) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.
DB13148Coagulation factor X humanCoagulation Factor X (Human), is a plasma-derived human blood coagulation factor is indicated for subjects with hereditary Factor X deficiency for: •On-demand treatment and control of bleeding episodes •Perioperative management of bleeding in patients with mild hereditary Factor X deficiency
DB13149Protein S humanFor use in the emergency reversal of coagulation factor deficiency in patients recieving vitamin K antagonist therapy [FDA Label]. Protein S is administered as part of a cocktail containing several other coagulation factors.
DB13150Coagulation factor VII humanMay be administered in cases of uncontrolled bleeding. Factor VII alone can be used in the treatment of congenital hemophilia A or B, acquired hemophilia, congenital factor VII deficiency, and Glanzmann's thrombasthenia. Off label use in the treatment of refractory bleeding after cardiac surgery and warfarin related intracerebral hemorrhage. Brands for human factor VII are currently only in combination with other vitamin K coagulation factors and can be used to reverse vitamin K antagonist activity in patients with acute major bleeds or for urgent surgery/invasive procedures.
DB13166ZofenoprilNot Available
DB13191PhosphocreatinePhosphocreatine is a naturally occuring substance that is found predominantly in the skeletal muscles of vertebrates. Its primary utility within the body is to serve in the maintanence and recycling of adenosine triphosphate (ATP) for muscular activity like contractions. Given this utility of phosphocreatine to recycle ATP, the most plausible therapeutic potentials for its use involve conditions caused by energy shortage or by increased energy requirements - such as in ischemic stroke and other cerebrovascular diseases. It is important to note however that relatively little clinical research has been done to significantly further the evidence for any such indications, although it is administered intravenously for cardiovascular conditions in some countries. Additionally, because phosphocreatine is not regulated as a controlled substance it is taken as a supplement by some professional athletes as a means to perhaps increase short bursts of muscle strength or energy for professional athletics.
DB13192Antihemophilic factor humanNot Available
DB13233AlaproclateNot Available
DB13301Magnesium pidolateNot Available
DB13359Magnesium aspartateNot Available
DrugDrug NameTargetType
DB00001LepirudinProthrombintarget
DB00002CetuximabEpidermal growth factor receptortarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00002CetuximabComplement C1r subcomponenttarget
DB00002CetuximabComplement C1q subcomponent subunit Atarget
DB00002CetuximabComplement C1q subcomponent subunit Btarget
DB00002CetuximabComplement C1q subcomponent subunit Ctarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00002CetuximabComplement C1s subcomponenttarget
DB00002CetuximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00002CetuximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00003Dornase alfaDNAtarget
DB00004Denileukin diftitoxInterleukin-2 receptor subunit alphatarget
DB00004Denileukin diftitoxCytokine receptor common subunit gammatarget
DB00004Denileukin diftitoxInterleukin-2 receptor subunit betatarget
DB00005EtanerceptTumor necrosis factortarget
DB00005EtanerceptLymphotoxin-alphatarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00005EtanerceptComplement C1r subcomponenttarget
DB00005EtanerceptComplement C1q subcomponent subunit Atarget
DB00005EtanerceptComplement C1q subcomponent subunit Btarget
DB00005EtanerceptComplement C1q subcomponent subunit Ctarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00005EtanerceptComplement C1s subcomponenttarget
DB00005EtanerceptHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00005EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00005EtanerceptTumor necrosis factor receptor superfamily member 1Btarget
DB00005EtanerceptProstaglandin G/H synthase 2enzyme
DB00006BivalirudinProthrombintarget
DB00006BivalirudinMyeloperoxidaseenzyme
DB00007LeuprolideGonadotropin-releasing hormone receptortarget
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 2target
DB00008Peginterferon alfa-2aInterferon alpha/beta receptor 1target
DB00008Peginterferon alfa-2aCytochrome P450 1A2enzyme
DB00009AlteplaseUrokinase plasminogen activator surface receptortarget
DB00009AlteplaseFibrinogen alpha chaintarget
DB00009AlteplasePlasminogentarget
DB00009AlteplasePlasminogen activator inhibitor 1target
DB00010SermorelinGrowth hormone-releasing hormone receptortarget
DB00011Interferon alfa-n1Interferon alpha/beta receptor 2target
DB00011Interferon alfa-n1Interferon alpha/beta receptor 1target
DB00012Darbepoetin alfaErythropoietin receptortarget
DB00013UrokinaseUrokinase plasminogen activator surface receptortarget
DB00013UrokinasePlasminogentarget
DB00013UrokinaseUrokinase-type plasminogen activatortarget
DB00013UrokinaseTissue-type plasminogen activatortarget
DB00013UrokinasePlasminogen activator inhibitor 2target
DB00013UrokinasePlasminogen activator inhibitor 1target
DB00013UrokinasePlasma serine protease inhibitortarget
DB00013UrokinaseNidogen-1target
DB00013UrokinaseLow-density lipoprotein receptor-related protein 2target
DB00013UrokinaseSuppressor of tumorigenicity 14 proteintarget
DB00014GoserelinLutropin-choriogonadotropic hormone receptortarget
DB00014GoserelinGonadotropin-releasing hormone receptortarget
DB00015ReteplaseUrokinase plasminogen activator surface receptortarget
DB00015ReteplaseFibrinogen alpha chaintarget
DB00015ReteplasePlasminogentarget
DB00015ReteplasePlasminogen activator inhibitor 1target
DB00016ErythropoietinErythropoietin receptortarget
DB00017Salmon CalcitoninCalcitonin receptortarget
DB00018Interferon alfa-n3Interferon alpha/beta receptor 1target
DB00018Interferon alfa-n3Interferon alpha/beta receptor 2target
DB00019PegfilgrastimGranulocyte colony-stimulating factor receptortarget
DB00019PegfilgrastimNeutrophil elastasetarget
DB00020SargramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
DB00020SargramostimBone marrow proteoglycantarget
DB00020SargramostimInterleukin-3 receptor subunit alphatarget
DB00020SargramostimCytokine receptor common subunit betatarget
DB00020SargramostimSyndecan-2target
DB00021SecretinSecretin receptortarget
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 1target
DB00022Peginterferon alfa-2bInterferon alpha/beta receptor 2target
DB00022Peginterferon alfa-2bCytochrome P450 1A2enzyme
DB00022Peginterferon alfa-2bCytochrome P450 2D6enzyme
DB00024Thyrotropin AlfaThyrotropin receptortarget
DB00025Antihemophilic factor, human recombinantCoagulation factor Xtarget
DB00025Antihemophilic factor, human recombinantPhytanoyl-CoA dioxygenase, peroxisomaltarget
DB00025Antihemophilic factor, human recombinantCoagulation factor IXtarget
DB00025Antihemophilic factor, human recombinantAsialoglycoprotein receptor 2target
DB00025Antihemophilic factor, human recombinant78 kDa glucose-regulated proteintarget
DB00025Antihemophilic factor, human recombinantCalreticulintarget
DB00025Antihemophilic factor, human recombinantCalnexintarget
DB00025Antihemophilic factor, human recombinantProtein ERGIC-53target
DB00025Antihemophilic factor, human recombinantProlow-density lipoprotein receptor-related protein 1target
DB00025Antihemophilic factor, human recombinantMultiple coagulation factor deficiency protein 2target
DB00025Antihemophilic factor, human recombinantvon Willebrand factortarget
DB00025Antihemophilic factor, human recombinantProthrombinenzyme
DB00025Antihemophilic factor, human recombinantVitamin K-dependent protein Cenzyme
DB00026AnakinraInterleukin-1 receptor type 1target
DB00027Gramicidin DMultidrug resistance protein 1transporter
DB00028Immune Globulin HumanLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00028Immune Globulin HumanLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00028Immune Globulin HumanHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00028Immune Globulin HumanLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00028Immune Globulin HumanLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00028Immune Globulin HumanLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00028Immune Globulin HumanHigh affinity immunoglobulin gamma Fc receptor IBtarget
DB00028Immune Globulin HumanComplement C3target
DB00028Immune Globulin HumanComplement C4-Atarget
DB00028Immune Globulin HumanComplement C4-Btarget
DB00028Immune Globulin HumanComplement C5target
DB00029AnistreplaseUrokinase plasminogen activator surface receptortarget
DB00029AnistreplaseFibrinogen alpha chaintarget
DB00029AnistreplasePlasminogentarget
DB00029AnistreplasePlasminogen activator inhibitor 1target
DB00030Insulin HumanInsulin receptortarget
DB00030Insulin HumanRetinoblastoma-associated proteintarget
DB00030Insulin HumanCathepsin Dtarget
DB00030Insulin HumanInsulin-like growth factor 1 receptortarget
DB00030Insulin HumanInsulin-degrading enzymetarget
DB00030Insulin HumanNeuroendocrine convertase 2target
DB00030Insulin HumanCarboxypeptidase Etarget
DB00030Insulin HumanNeuroendocrine convertase 1target
DB00030Insulin HumanProtein NOV homologtarget
DB00030Insulin HumanLow-density lipoprotein receptor-related protein 2target
DB00030Insulin HumanInsulin-like growth factor-binding protein 7target
DB00030Insulin HumanSynaptotagmin-like protein 4target
DB00030Insulin HumanCytochrome P450 1A2enzyme
DB00031TenecteplaseUrokinase plasminogen activator surface receptortarget
DB00031TenecteplasePlasminogen activator inhibitor 1target
DB00031TenecteplaseFibrinogen alpha chaintarget
DB00031TenecteplasePlasminogen activator inhibitor 2target
DB00031TenecteplaseTetranectintarget
DB00031TenecteplaseKeratin, type II cytoskeletal 8target
DB00031TenecteplaseAnnexin A2target
DB00031TenecteplaseCalreticulintarget
DB00031TenecteplaseCalnexintarget
DB00031TenecteplaseProlow-density lipoprotein receptor-related protein 1target
DB00031TenecteplasePlasminogentarget
DB00032MenotropinsFollicle-stimulating hormone receptortarget
DB00032MenotropinsLutropin-choriogonadotropic hormone receptortarget
DB00033Interferon gamma-1bInterferon gamma receptor 1target
DB00033Interferon gamma-1bInterferon gamma receptor 2target
DB00033Interferon gamma-1bCytochrome P450 1A2enzyme
DB00034Interferon Alfa-2a, RecombinantInterferon alpha/beta receptor 1target
DB00034Interferon Alfa-2a, RecombinantInterferon alpha/beta receptor 2target
DB00035DesmopressinVasopressin V1a receptortarget
DB00035DesmopressinVasopressin V1b receptortarget
DB00035DesmopressinVasopressin V2 receptortarget
DB00035DesmopressinProstaglandin G/H synthase 1enzyme
DB00035DesmopressinProstaglandin G/H synthase 2enzyme
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor Xtarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factortarget
DB00036Coagulation factor VIIa Recombinant HumanSerine protease hepsintarget
DB00036Coagulation factor VIIa Recombinant HumanTissue factor pathway inhibitortarget
DB00036Coagulation factor VIIa Recombinant HumanVitamin K-dependent gamma-carboxylasetarget
DB00036Coagulation factor VIIa Recombinant HumanCoagulation factor VIItarget
DB00038OprelvekinInterleukin-11 receptor subunit alphatarget
DB00039PaliferminFibroblast growth factor receptor 2target
DB00039PaliferminNeuropilin-1target
DB00039PaliferminFibroblast growth factor receptor 1target
DB00039PaliferminFibroblast growth factor receptor 4target
DB00039PaliferminFibroblast growth factor receptor 3target
DB00039PaliferminBasement membrane-specific heparan sulfate proteoglycan core proteintarget
DB00040Glucagon recombinantGlucagon receptortarget
DB00040Glucagon recombinantGlucagon-like peptide 2 receptortarget
DB00040Glucagon recombinantGlucagon-like peptide 1 receptortarget
DB00041AldesleukinInterleukin-2 receptor subunit betatarget
DB00041AldesleukinInterleukin-2 receptor subunit alphatarget
DB00041AldesleukinCytokine receptor common subunit gammatarget
DB00041AldesleukinProstaglandin G/H synthase 2enzyme
DB00041AldesleukinCytosolic phospholipase A2enzyme
DB00041AldesleukinCytochrome P450 3A4enzyme
DB00041AldesleukinXanthine dehydrogenase/oxidaseenzyme
DB00041AldesleukinCytochrome P450 2E1enzyme
DB00042Botulinum Toxin Type BVesicle-associated membrane protein 1target
DB00042Botulinum Toxin Type BVesicle-associated membrane protein 2target
DB00042Botulinum Toxin Type BSynaptotagmin-2target
DB00043OmalizumabHigh affinity immunoglobulin epsilon receptor subunit alphatarget
DB00043OmalizumabHigh affinity immunoglobulin epsilon receptor subunit betatarget
DB00044Lutropin alfaLutropin-choriogonadotropic hormone receptortarget
DB00046Insulin LisproInsulin receptortarget
DB00046Insulin LisproInsulin-like growth factor 1 receptortarget
DB00046Insulin LisproCytochrome P450 1A2enzyme
DB00047Insulin GlargineInsulin receptortarget
DB00047Insulin GlargineInsulin-like growth factor 1 receptortarget
DB00047Insulin GlargineCytochrome P450 1A2enzyme
DB00050CetrorelixLutropin-choriogonadotropic hormone receptortarget
DB00050CetrorelixGonadotropin-releasing hormone receptortarget
DB00051AdalimumabTumor necrosis factortarget
DB00051AdalimumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00051AdalimumabComplement C1r subcomponenttarget
DB00051AdalimumabComplement C1q subcomponent subunit Atarget
DB00051AdalimumabComplement C1q subcomponent subunit Btarget
DB00051AdalimumabComplement C1q subcomponent subunit Ctarget
DB00051AdalimumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00051AdalimumabComplement C1s subcomponenttarget
DB00051AdalimumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00051AdalimumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00051AdalimumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00051AdalimumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00052SomatotropinGrowth hormone receptortarget
DB00052SomatotropinProlactin receptortarget
DB00054AbciximabIntegrin beta-3target
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00054AbciximabComplement C1r subcomponenttarget
DB00054AbciximabComplement C1q subcomponent subunit Atarget
DB00054AbciximabComplement C1q subcomponent subunit Btarget
DB00054AbciximabComplement C1q subcomponent subunit Ctarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00054AbciximabComplement C1s subcomponenttarget
DB00054AbciximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00054AbciximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00054AbciximabIntegrin alpha-IIbtarget
DB00054AbciximabVitronectintarget
DB00055Drotrecogin alfaCoagulation factor VIIItarget
DB00055Drotrecogin alfaCoagulation factor Vtarget
DB00055Drotrecogin alfaPlasminogen activator inhibitor 1target
DB00055Drotrecogin alfaThrombomodulintarget
DB00055Drotrecogin alfaVitamin K-dependent protein Starget
DB00055Drotrecogin alfaCeruloplasmintarget
DB00055Drotrecogin alfaProthrombintarget
DB00055Drotrecogin alfaPlatelet factor 4target
DB00055Drotrecogin alfaPlasma serine protease inhibitortarget
DB00055Drotrecogin alfaSerpin B6target
DB00055Drotrecogin alfaVitamin K-dependent gamma-carboxylasetarget
DB00055Drotrecogin alfaEndothelial protein C receptortarget
DB00056Gemtuzumab ozogamicinMyeloid cell surface antigen CD33target
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00056Gemtuzumab ozogamicinComplement C1r subcomponenttarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Atarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Btarget
DB00056Gemtuzumab ozogamicinComplement C1q subcomponent subunit Ctarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00056Gemtuzumab ozogamicinComplement C1s subcomponenttarget
DB00056Gemtuzumab ozogamicinHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00056Gemtuzumab ozogamicinLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00057Indium In-111 satumomab pendetideTumor-associated glycoprotein 72 (TAG-72)target
DB00058Alpha-1-proteinase inhibitorNeutrophil elastasetarget
DB00060Interferon beta-1aInterferon alpha/beta receptor 1target
DB00060Interferon beta-1aInterferon alpha/beta receptor 2target
DB00062Human Serum AlbuminApolipoprotein Etarget
DB00062Human Serum AlbuminSerum amyloid A-1 proteintarget
DB00062Human Serum AlbuminProtein AMBPtarget
DB00062Human Serum AlbuminCytochrome P450 2C9enzyme
DB00062Human Serum AlbuminMyeloperoxidaseenzyme
DB00062Human Serum AlbuminUDP-glucuronosyltransferase 1-9enzyme
DB00063EptifibatideIntegrin beta-3target
DB00065InfliximabTumor necrosis factortarget
DB00066FollitropinFollicle-stimulating hormone receptortarget
DB00067VasopressinVasopressin V1a receptortarget
DB00067VasopressinVasopressin V2 receptortarget
DB00067VasopressinVasopressin V1b receptortarget
DB00067VasopressinCanalicular multispecific organic anion transporter 1transporter
DB00068Interferon beta-1bInterferon alpha/beta receptor 1target
DB00068Interferon beta-1bInterferon alpha/beta receptor 2target
DB00069Interferon alfacon-1Interferon alpha/beta receptor 1target
DB00069Interferon alfacon-1Interferon alpha/beta receptor 2target
DB00070HyaluronidaseTransforming growth factor beta-1target
DB00070HyaluronidaseSerum albumincarrier
DB00070HyaluronidaseHyaluronantarget
DB00071Insulin PorkInsulin receptortarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ alpha 2 chaintarget
DB00071Insulin PorkHLA class II histocompatibility antigen, DQ beta 1 chaintarget
DB00071Insulin PorkRetinoblastoma-associated proteintarget
DB00071Insulin PorkCathepsin Dtarget
DB00071Insulin PorkInsulin-like growth factor 1 receptortarget
DB00071Insulin PorkInsulin-degrading enzymetarget
DB00071Insulin PorkNeuroendocrine convertase 2target
DB00071Insulin PorkCarboxypeptidase Etarget
DB00071Insulin PorkNeuroendocrine convertase 1target
DB00071Insulin PorkProtein NOV homologtarget
DB00071Insulin PorkLow-density lipoprotein receptor-related protein 2target
DB00071Insulin PorkInsulin-like growth factor-binding protein 7target
DB00071Insulin PorkSynaptotagmin-like protein 4target
DB00071Insulin PorkCytochrome P450 1A2enzyme
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00072TrastuzumabComplement C1r subcomponenttarget
DB00072TrastuzumabComplement C1q subcomponent subunit Atarget
DB00072TrastuzumabComplement C1q subcomponent subunit Btarget
DB00072TrastuzumabComplement C1q subcomponent subunit Ctarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00072TrastuzumabComplement C1s subcomponenttarget
DB00072TrastuzumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00072TrastuzumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00072TrastuzumabReceptor tyrosine-protein kinase erbB-2target
DB00072TrastuzumabEpidermal growth factor receptortarget
DB00072TrastuzumabCytochrome P450 19A1enzyme
DB00073RituximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00073RituximabComplement C1r subcomponenttarget
DB00073RituximabComplement C1q subcomponent subunit Atarget
DB00073RituximabComplement C1q subcomponent subunit Btarget
DB00073RituximabComplement C1q subcomponent subunit Ctarget
DB00073RituximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00073RituximabComplement C1s subcomponenttarget
DB00073RituximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00073RituximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00073RituximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00073RituximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00073RituximabB-lymphocyte antigen CD20target
DB00074BasiliximabInterleukin-2 receptor subunit alphatarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00074BasiliximabComplement C1r subcomponenttarget
DB00074BasiliximabComplement C1q subcomponent subunit Atarget
DB00074BasiliximabComplement C1q subcomponent subunit Btarget
DB00074BasiliximabComplement C1q subcomponent subunit Ctarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00074BasiliximabComplement C1s subcomponenttarget
DB00074BasiliximabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00074BasiliximabInterleukin-2 receptor subunit betatarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00074BasiliximabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00075MuromonabT-cell surface glycoprotein CD3 epsilon chaintarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00075MuromonabComplement C1r subcomponenttarget
DB00075MuromonabComplement C1q subcomponent subunit Atarget
DB00075MuromonabComplement C1q subcomponent subunit Btarget
DB00075MuromonabComplement C1q subcomponent subunit Ctarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00075MuromonabComplement C1s subcomponenttarget
DB00075MuromonabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00075MuromonabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00075MuromonabT-cell surface glycoprotein CD3 delta chaintarget
DB00075MuromonabT-cell surface glycoprotein CD3 gamma chaintarget
DB00075MuromonabT-cell surface glycoprotein CD3 zeta chaintarget
DB00078Ibritumomab tiuxetanB-lymphocyte antigen CD20target
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00078Ibritumomab tiuxetanComplement C1r subcomponenttarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Atarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Btarget
DB00078Ibritumomab tiuxetanComplement C1q subcomponent subunit Ctarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00078Ibritumomab tiuxetanComplement C1s subcomponenttarget
DB00078Ibritumomab tiuxetanHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00078Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00080DaptomycinBacterial outer membranetarget
DB00080DaptomycinLipoteichoic acid synthesistarget
DB00081TositumomabB-lymphocyte antigen CD20target
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00081TositumomabComplement C1r subcomponenttarget
DB00081TositumomabComplement C1q subcomponent subunit Atarget
DB00081TositumomabComplement C1q subcomponent subunit Btarget
DB00081TositumomabComplement C1q subcomponent subunit Ctarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00081TositumomabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00081TositumomabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00082PegvisomantGrowth hormone receptortarget
DB00082PegvisomantSterol 26-hydroxylase, mitochondrialenzyme
DB00082PegvisomantGlutamine synthetaseenzyme
DB00082PegvisomantCytochrome P450 2C18enzyme
DB00082PegvisomantCytochrome P450 3A4enzyme
DB00082PegvisomantCholinesteraseenzyme
DB00082PegvisomantCytochrome P450 2C19enzyme
DB00082PegvisomantCytochrome P450 4A11enzyme
DB00083Botulinum Toxin Type ASynaptosomal-associated protein 25target
DB00083Botulinum Toxin Type ARho-related GTP-binding protein RhoBtarget
DB00086StreptokinasePlasminogentarget
DB00086StreptokinaseProteinase-activated receptor 1target
DB00086StreptokinaseCytosolic phospholipase A2enzyme
DB00087AlemtuzumabCAMPATH-1 antigentarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00087AlemtuzumabComplement C1r subcomponenttarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Atarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Btarget
DB00087AlemtuzumabComplement C1q subcomponent subunit Ctarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00087AlemtuzumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00087AlemtuzumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00089Capromab pendetideGlutamate carboxypeptidase 2target
DB00091CyclosporineCalcium signal-modulating cyclophilin ligandtarget
DB00091CyclosporinePeptidyl-prolyl cis-trans isomerase Atarget
DB00091CyclosporineCalcineurin subunit B type 2target
DB00091CyclosporineCytochrome P450 3A5enzyme
DB00091CyclosporineCytochrome P450 3A4enzyme
DB00091CyclosporineCytochrome P450 3A7enzyme
DB00091CyclosporineMultidrug resistance protein 1transporter
DB00091CyclosporineCanalicular multispecific organic anion transporter 2transporter
DB00091CyclosporineBile salt export pumptransporter
DB00091CyclosporineMultidrug resistance-associated protein 1transporter
DB00091CyclosporineSolute carrier organic anion transporter family member 1A2transporter
DB00091CyclosporineIleal sodium/bile acid cotransportertransporter
DB00091CyclosporineSodium/bile acid cotransportertransporter
DB00091CyclosporineSolute carrier family 22 member 6transporter
DB00091CyclosporineMultidrug resistance-associated protein 7transporter
DB00091CyclosporineCanalicular multispecific organic anion transporter 1transporter
DB00091CyclosporineATP-binding cassette sub-family G member 2transporter
DB00091CyclosporineSolute carrier organic anion transporter family member 1B1transporter
DB00091CyclosporineCytochrome P450 2C19enzyme
DB00091CyclosporineCytochrome P450 2C8enzyme
DB00091CyclosporineCytochrome P450 2C9enzyme
DB00091CyclosporineCytochrome P450 2D6enzyme
DB00091CyclosporinePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
DB00092AlefaceptT-cell surface antigen CD2target
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00092AlefaceptComplement C1r subcomponenttarget
DB00092AlefaceptComplement C1q subcomponent subunit Atarget
DB00092AlefaceptComplement C1q subcomponent subunit Btarget
DB00092AlefaceptComplement C1q subcomponent subunit Ctarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00092AlefaceptHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00092AlefaceptLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00093FelypressinVasopressin V1a receptortarget
DB00094UrofollitropinFollicle-stimulating hormone receptortarget
DB00095EfalizumabIntegrin alpha-Ltarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00095EfalizumabComplement C1r subcomponenttarget
DB00095EfalizumabComplement C1q subcomponent subunit Atarget
DB00095EfalizumabComplement C1q subcomponent subunit Btarget
DB00095EfalizumabComplement C1q subcomponent subunit Ctarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00095EfalizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00095EfalizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00098Antithymocyte immunoglobulin (rabbit)T-cell surface glycoprotein CD1atarget
DB00098Antithymocyte immunoglobulin (rabbit)Major histocompatibility complex class I-related gene proteintarget
DB00098Antithymocyte immunoglobulin (rabbit)Integrin alpha-Ltarget
DB00098Antithymocyte immunoglobulin (rabbit)T-lymphocyte activation antigen CD86target
DB00098Antithymocyte immunoglobulin (rabbit)Low affinity immunoglobulin gamma Fc region receptor II-btarget
DB00098Antithymocyte immunoglobulin (rabbit)T-cell surface glycoprotein CD4target
DB00098Antithymocyte immunoglobulin (rabbit)Integrin beta-1target
DB00098Antithymocyte immunoglobulin (rabbit)Integrin alpha-Vtarget
DB00098Antithymocyte immunoglobulin (rabbit)Integrin beta-3target
DB00099FilgrastimGranulocyte colony-stimulating factor receptortarget
DB00099FilgrastimNeutrophil elastasetarget
DB00102BecaplerminPlatelet-derived growth factor receptor betatarget
DB00102BecaplerminAlpha-2-macroglobulintarget
DB00102BecaplerminPlatelet-derived growth factor receptor alphatarget
DB00103Agalsidase betaGlobotriaosylceramidetarget
DB00104OctreotideSomatostatin receptor type 1target
DB00104OctreotideSomatostatin receptor type 5target
DB00104OctreotideSomatostatin receptor type 2target
DB00104OctreotideMyeloperoxidaseenzyme
DB00105Interferon Alfa-2b, RecombinantInterferon alpha/beta receptor 2target
DB00105Interferon Alfa-2b, RecombinantInterferon alpha/beta receptor 1target
DB00105Interferon Alfa-2b, RecombinantCytochrome P450 1A2enzyme
DB00106AbarelixGonadotropin-releasing hormone receptortarget
DB00107OxytocinOxytocin-neurophysin 1target
DB00107OxytocinOxytocin receptortarget
DB00107OxytocinProlyl endopeptidaseenzyme
DB00108NatalizumabIntegrin alpha-4target
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00108NatalizumabComplement C1r subcomponenttarget
DB00108NatalizumabComplement C1q subcomponent subunit Atarget
DB00108NatalizumabComplement C1q subcomponent subunit Btarget
DB00108NatalizumabComplement C1q subcomponent subunit Ctarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00108NatalizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00108NatalizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00108NatalizumabIntercellular adhesion molecule 1target
DB00109EnfuvirtideEnvelope glycoproteintarget
DB00109EnfuvirtideCytochrome P450 2C19enzyme
DB00109EnfuvirtideCytochrome P450 2E1enzyme
DB00110PalivizumabFusion glycoprotein F0target
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00110PalivizumabComplement C1r subcomponenttarget
DB00110PalivizumabComplement C1q subcomponent subunit Atarget
DB00110PalivizumabComplement C1q subcomponent subunit Btarget
DB00110PalivizumabComplement C1q subcomponent subunit Ctarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00110PalivizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00110PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00111DaclizumabInterleukin-2 receptor subunit alphatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00111DaclizumabComplement C1r subcomponenttarget
DB00111DaclizumabComplement C1q subcomponent subunit Atarget
DB00111DaclizumabComplement C1q subcomponent subunit Btarget
DB00111DaclizumabComplement C1q subcomponent subunit Ctarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00111DaclizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00111DaclizumabInterleukin-2 receptor subunit betatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00112BevacizumabComplement C1r subcomponenttarget
DB00112BevacizumabComplement C1q subcomponent subunit Atarget
DB00112BevacizumabComplement C1q subcomponent subunit Btarget
DB00112BevacizumabComplement C1q subcomponent subunit Ctarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00112BevacizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00112BevacizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB00112BevacizumabVascular endothelial growth factor Atarget
DB00113Technetium Tc-99m arcitumomabCarcinoembryonic antigen-related cell adhesion molecule 1target
DB00117HistidineHistidine decarboxylasetarget
DB00117HistidineHistidine--tRNA ligase, cytoplasmictarget
DB00117HistidineSodium-coupled neutral amino acid transporter 3target
DB00117HistidineHistidine ammonia-lyasetarget
DB00117HistidineMonocarboxylate transporter 10transporter
DB00118AdemetionineGlycine N-methyltransferasetarget
DB00118AdemetionineS-adenosylmethionine decarboxylase proenzymetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-2target
DB00118AdemetionineCystathionine beta-synthasetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-1target
DB00118AdemetionineCytochrome P450 2E1enzyme
DB00118AdemetionineCatechol O-methyltransferasetarget
DB00118AdemetionineSpermidine synthaseenzyme
DB00118AdemetionineCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1target
DB00118AdemetionineArsenite methyltransferasetarget
DB00120L-PhenylalanineTyrosine aminotransferasetarget
DB00120L-PhenylalanineLarge neutral amino acids transporter small subunit 2target
DB00120L-PhenylalaninePhenylalanine--tRNA ligase alpha subunittarget
DB00120L-PhenylalaninePhenylalanine-4-hydroxylasetarget
DB00120L-PhenylalaninePhenylalanine--tRNA ligase, mitochondrialtarget
DB00120L-PhenylalaninePhenylalanine--tRNA ligase beta subunittarget
DB00120L-PhenylalanineTyrosine 3-monooxygenasetarget
DB00120L-PhenylalanineMonocarboxylate transporter 10transporter
DB00123L-LysineHigh affinity cationic amino acid transporter 1target
DB00123L-LysineCationic amino acid transporter 4target
DB00123L-LysineCationic amino acid transporter 3target
DB00123L-LysineLow affinity cationic amino acid transporter 2target
DB00123L-LysineLysine--tRNA ligasetarget
DB00123L-LysineMonocarboxylate transporter 10transporter
DB00123L-LysineSolute carrier family 22 member 4transporter
DB00125L-ArginineCationic amino acid transporter 3target
DB00125L-ArginineArginine decarboxylasetarget
DB00125L-ArginineArgininosuccinate lyasetarget
DB00125L-ArginineNitric oxide synthase, inducibletarget
DB00125L-ArginineHigh affinity cationic amino acid transporter 1target
DB00125L-ArginineArginase-2, mitochondrialtarget
DB00125L-ArginineCationic amino acid transporter 4target
DB00125L-ArginineArgininosuccinate synthasetarget
DB00125L-ArginineNitric oxide synthase, endothelialtarget
DB00125L-ArginineSolute carrier family 22 member 5transporter
DB00125L-ArginineMonocarboxylate transporter 10transporter
DB00125L-ArginineSolute carrier family 22 member 4transporter
DB00128L-Aspartic AcidCalcium-binding mitochondrial carrier protein Aralar2target
DB00128L-Aspartic AcidAspartate aminotransferase, cytoplasmictarget
DB00128L-Aspartic AcidAspartoacylasetarget
DB00128L-Aspartic AcidAsparagine synthetase [glutamine-hydrolyzing]target
DB00128L-Aspartic AcidArgininosuccinate synthasetarget
DB00128L-Aspartic AcidAminoacylase-1target
DB00128L-Aspartic AcidAspartate aminotransferase, mitochondrialtarget
DB00128L-Aspartic AcidAspartate--tRNA ligase, cytoplasmictarget
DB00128L-Aspartic AcidCalcium-binding mitochondrial carrier protein Aralar1target
DB00128L-Aspartic AcidAspartyl/asparaginyl beta-hydroxylasetarget
DB00128L-Aspartic AcidMultifunctional protein ADE2target
DB00128L-Aspartic AcidCAD proteintarget
DB00128L-Aspartic AcidAdenylosuccinate synthetase isozyme 2target
DB00128L-Aspartic AcidExcitatory amino acid transporter 3target
DB00128L-Aspartic AcidAspartate aminotransferasetarget
DB00128L-Aspartic AcidArgininosuccinate synthetase, isoform CRA_atarget
DB00128L-Aspartic AcidAspartate--tRNA ligase, mitochondrialtarget
DB00128L-Aspartic AcidIsoaspartyl peptidase/L-asparaginasetarget
DB00128L-Aspartic AcidAdenylosuccinate synthetase isozyme 1target
DB00128L-Aspartic AcidAspartoacylase-2target
DB00128L-Aspartic AcidRibonuclease pancreatictarget
DB00128L-Aspartic AcidLysozyme Ctarget
DB00128L-Aspartic AcidMonocarboxylate transporter 10transporter
DB00130L-GlutamineCTP synthase 1target
DB00130L-GlutamineAmidophosphoribosyltransferasetarget
DB00130L-GlutamineGlutamine synthetasetarget
DB00130L-GlutamineMonocarboxylate transporter 10transporter
DB00130L-GlutamineCoagulation factor XIII A chainenzyme
DB00130L-GlutamineGlutaminase kidney isoform, mitochondrialenzyme
DB00130L-GlutamineGlutaminase liver isoform, mitochondrialenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 2enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 5enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 6enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Kenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase 4enzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Eenzyme
DB00130L-GlutamineProtein-glutamine gamma-glutamyltransferase Zenzyme
DB00130L-GlutamineSodium-coupled neutral amino acid transporter 3transporter
DB00130L-GlutamineNeutral amino acid transporter B(0)transporter
DB00130L-GlutamineGMP synthase [glutamine-hydrolyzing]enzyme
DB00130L-GlutamineAsparagine synthetase [glutamine-hydrolyzing]enzyme
DB00130L-GlutamineKynurenine--oxoglutarate transaminase 1enzyme
DB00130L-GlutaminePhosphoribosylformylglycinamidine synthaseenzyme
DB00130L-GlutamineGlutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrialenzyme
DB00130L-GlutamineGlutamine--fructose-6-phosphate aminotransferase [isomerizing] 2enzyme
DB00130L-GlutamineCAD proteinenzyme
DB00130L-GlutamineGlutamine--tRNA ligaseenzyme
DB00130L-GlutamineGlutamine-dependent NAD(+) synthetaseenzyme
DB00130L-GlutamineLarge neutral amino acids transporter small subunit 2transporter
DB00133SerineCystathionine beta-synthasetarget
DB00133SerineL-serine dehydratase/L-threonine deaminasetarget
DB00133SerineSerine racemasetarget
DB00133SerineSerine palmitoyltransferase 2target
DB00133SerineSerine palmitoyltransferase 1target
DB00133SerineSerine--tRNA ligase, cytoplasmictarget
DB00133SerineSerine--pyruvate aminotransferasetarget
DB00133SerineMonocarboxylate transporter 10transporter
DB00134L-MethionineMethionine synthase reductasetarget
DB00134L-MethionineMethionine synthasetarget
DB00134L-MethionineMethionine aminopeptidase 2target
DB00134L-MethionineBetaine--homocysteine S-methyltransferase 1target
DB00134L-MethionineS-methylmethionine--homocysteine S-methyltransferase BHMT2target
DB00134L-MethionineGlutamine synthetaseenzyme
DB00134L-MethionineMethylenetetrahydrofolate reductaseenzyme
DB00134L-MethionineMonocarboxylate transporter 10transporter
DB00134L-MethionineS-adenosylmethionine synthase isoform type-2enzyme
DB00134L-MethionineMethionine-R-sulfoxide reductase B2, mitochondrialenzyme
DB00134L-MethionineS-adenosylmethionine synthase isoform type-1enzyme
DB00134L-MethionineMethionine-R-sulfoxide reductase B1enzyme
DB00134L-MethionineMitochondrial peptide methionine sulfoxide reductaseenzyme
DB00134L-MethionineMethionine--tRNA ligase, cytoplasmicenzyme
DB00134L-MethionineMethionine--tRNA ligase, mitochondrialenzyme
DB00134L-MethionineMethionine adenosyltransferase 2 subunit betaenzyme
DB00135L-TyrosineTyrosine 3-monooxygenasetarget
DB00135L-TyrosineTyrosine--tRNA ligase, mitochondrialtarget
DB00135L-TyrosineTyrosine--tRNA ligase, cytoplasmictarget
DB00135L-TyrosineTyrosine aminotransferasetarget
DB00135L-TyrosineMonocarboxylate transporter 8transporter
DB00135L-TyrosineMonocarboxylate transporter 10transporter
DB00138CystineCystine/glutamate transportertarget
DB00138CystineCystinosintarget
DB00138CystineB(0,+)-type amino acid transporter 1target
DB00138CystineNeutral and basic amino acid transport protein rBATtarget
DB00138CystineMonocarboxylate transporter 10transporter
DB00142Glutamic AcidGlutamate dehydrogenase 1, mitochondrialtarget
DB00142Glutamic AcidGlutamate receptor ionotropic, kainate 1target
DB00142Glutamic AcidGlutamate receptor 1target
DB00142Glutamic AcidGlutamate--cysteine ligase regulatory subunittarget
DB00142Glutamic AcidGlutamate carboxypeptidase 2target
DB00142Glutamic AcidGlutamate decarboxylase 2target
DB00142Glutamic AcidGlutamate decarboxylase 1target
DB00142Glutamic AcidFormimidoyltransferase-cyclodeaminasetarget
DB00142Glutamic AcidGlutamate receptor 2target
DB00142Glutamic AcidGlutamate receptor 3target
DB00142Glutamic AcidGlutamate receptor 4target
DB00142Glutamic AcidDelta-1-pyrroline-5-carboxylate synthasetarget
DB00142Glutamic AcidGlutamate receptor ionotropic, kainate 2target
DB00142Glutamic AcidGlutamate receptor ionotropic, kainate 3target
DB00142Glutamic AcidMetabotropic glutamate receptor 1target
DB00142Glutamic AcidMetabotropic glutamate receptor 4target
DB00142Glutamic AcidGlutamate receptor ionotropic, kainate 4target
DB00142Glutamic AcidGlutamate receptor ionotropic, kainate 5target
DB00142Glutamic AcidMetabotropic glutamate receptor 7target
DB00142Glutamic AcidMetabotropic glutamate receptor 8target
DB00142Glutamic AcidExcitatory amino acid transporter 5target
DB00142Glutamic Acid5-oxoprolinasetarget
DB00142Glutamic AcidPhosphoribosylformylglycinamidine synthasetarget
DB00142Glutamic AcidBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 2Dtarget
DB00142Glutamic AcidGlutamate receptor ionotropic, delta-2target
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 3Btarget
DB00142Glutamic AcidGlutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrialtarget
DB00142Glutamic AcidGlutaminase kidney isoform, mitochondrialtarget
DB00142Glutamic AcidAspartate aminotransferase, mitochondrialtarget
DB00142Glutamic AcidBifunctional glutamate/proline--tRNA ligasetarget
DB00142Glutamic AcidAsparagine synthetase [glutamine-hydrolyzing]target
DB00142Glutamic AcidGlutamine synthetasetarget
DB00142Glutamic AcidAspartate aminotransferase, cytoplasmictarget
DB00142Glutamic AcidTyrosine aminotransferasetarget
DB00142Glutamic AcidAlanine aminotransferase 1target
DB00142Glutamic AcidVitamin K-dependent gamma-carboxylasetarget
DB00142Glutamic AcidExcitatory amino acid transporter 1target
DB00142Glutamic AcidExcitatory amino acid transporter 2target
DB00142Glutamic AcidExcitatory amino acid transporter 3target
DB00142Glutamic AcidGlutamate--cysteine ligase catalytic subunittarget
DB00142Glutamic AcidExcitatory amino acid transporter 4target
DB00142Glutamic AcidGlutamate dehydrogenase 2, mitochondrialtarget
DB00142Glutamic AcidGMP synthase [glutamine-hydrolyzing]target
DB00142Glutamic AcidBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00142Glutamic Acid4-aminobutyrate aminotransferase, mitochondrialtarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 1target
DB00142Glutamic AcidFolylpolyglutamate synthase, mitochondrialtarget
DB00142Glutamic AcidGlutamyl aminopeptidasetarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 2Atarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 2Btarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 2Ctarget
DB00142Glutamic AcidAspartate aminotransferasetarget
DB00142Glutamic AcidProbable glutamate--tRNA ligase, mitochondrialtarget
DB00142Glutamic AcidLengsintarget
DB00142Glutamic AcidGlutamine-dependent NAD(+) synthetasetarget
DB00142Glutamic AcidKynurenine--oxoglutarate transaminase 3target
DB00142Glutamic AcidN-acetylglutamate synthase, mitochondrialtarget
DB00142Glutamic AcidKynurenine/alpha-aminoadipate aminotransferase, mitochondrialtarget
DB00142Glutamic AcidGlutamate receptor ionotropic, NMDA 3Atarget
DB00142Glutamic AcidAlanine aminotransferase 2target
DB00142Glutamic AcidMitochondrial glutamate carrier 2target
DB00142Glutamic AcidMitochondrial glutamate carrier 1target
DB00142Glutamic AcidAlpha-aminoadipic semialdehyde synthase, mitochondrialtarget
DB00142Glutamic AcidGlutaminase liver isoform, mitochondrialtarget
DB00142Glutamic AcidAspartyl aminopeptidasetarget
DB00142Glutamic AcidGlutamate receptor ionotropic, delta-1target
DB00142Glutamic AcidCystine/glutamate transportertarget
DB00142Glutamic AcidCarboxypeptidase Qtarget
DB00142Glutamic AcidPhosphoserine aminotransferasetarget
DB00142Glutamic AcidMonocarboxylate transporter 10transporter
DB00142Glutamic AcidMonocarboxylate transporter 1transporter
DB00143GlutathioneGlutathione reductase, mitochondrialtarget
DB00143GlutathioneGlutathione synthetasetarget
DB00143GlutathioneGlutathione S-transferase Mu 1target
DB00143GlutathioneGlutathione S-transferase kappa 1target
DB00143GlutathioneGlutathione S-transferase A3target
DB00143GlutathioneGlutathione S-transferase Mu 3target
DB00143GlutathioneGlutathione S-transferase A4target
DB00143GlutathioneGlutathione S-transferase Mu 4target
DB00143GlutathioneGlutathione S-transferase A5target
DB00143GlutathioneGlutathione S-transferase Ptarget
DB00143GlutathioneGlutathione S-transferase omega-1target
DB00143GlutathioneGlutathione peroxidase 1target
DB00143GlutathioneGlutathione peroxidase 2target
DB00143GlutathioneGlutathione S-transferase theta-1target
DB00143GlutathioneMaleylacetoacetate isomerasetarget
DB00143GlutathioneEpididymal secretory glutathione peroxidasetarget
DB00143GlutathioneGlutathione peroxidase 3target
DB00143GlutathioneLactoylglutathione lyasetarget
DB00143GlutathioneLeukotriene C4 synthasetarget
DB00143GlutathioneMicrosomal glutathione S-transferase 3target
DB00143GlutathioneHematopoietic prostaglandin D synthasetarget
DB00143GlutathioneThioredoxin domain-containing protein 12target
DB00143GlutathioneGlutathione S-transferase A1target
DB00143GlutathioneGlutathione S-transferase A2target
DB00143GlutathioneMicrosomal glutathione S-transferase 1target
DB00143GlutathioneS-formylglutathione hydrolasetarget
DB00143GlutathioneGamma-glutamyltranspeptidase 1target
DB00143GlutathioneGlutathione S-transferase Mu 2target
DB00143GlutathioneGlutaredoxin-1target
DB00143GlutathionePhospholipid hydroperoxide glutathione peroxidase, mitochondrialtarget
DB00143GlutathioneGlutathione S-transferase Mu 5target
DB00143GlutathioneGlutathione peroxidase 6target
DB00143GlutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
DB00143GlutathioneGlutathione peroxidasetarget
DB00143GlutathioneProbable glutathione peroxidase 8target
DB00143GlutathioneGlutathione peroxidase 7target
DB00143GlutathioneMicrosomal glutathione S-transferase 2target
DB00143GlutathioneGlutathione S-transferase omega-2target
DB00143GlutathioneGlutaredoxin-2, mitochondrialtarget
DB00143GlutathioneGlutathione S-transferase A2enzyme
DB00143GlutathioneGlutathione S-transferase A1enzyme
DB00143GlutathioneMultidrug resistance-associated protein 1transporter
DB00143GlutathioneCanalicular multispecific organic anion transporter 1transporter
DB00143GlutathioneCanalicular multispecific organic anion transporter 2transporter
DB00143GlutathioneMultidrug resistance-associated protein 4transporter
DB00143GlutathioneMultidrug resistance-associated protein 5transporter
DB00143GlutathioneAldose reductasetarget
DB00143GlutathioneMatrix metalloproteinase-9target
DB00143GlutathioneCytochrome P450 3A4target
DB00145GlycineGlutathione synthetasetarget
DB00145GlycineGlycine receptor subunit alpha-1target
DB00145GlycineSerine--pyruvate aminotransferasetarget
DB00145GlycineGlycine receptor subunit betatarget
DB00145GlycineSerine hydroxymethyltransferase, cytosolictarget
DB00145GlycineGlycine receptor subunit alpha-3target
DB00145GlycineGlycine receptor subunit alpha-2target
DB00145GlycineGlycine N-methyltransferasetarget
DB00145GlycineGlycine amidinotransferase, mitochondrialtarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 3Btarget
DB00145GlycineGlycine dehydrogenase [decarboxylating], mitochondrialtarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 1target
DB00145Glycine2-amino-3-ketobutyrate coenzyme A ligase, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, nonspecific, mitochondrialtarget
DB00145Glycine5-aminolevulinate synthase, erythroid-specific, mitochondrialtarget
DB00145GlycineGlycine cleavage system H protein, mitochondrialtarget
DB00145GlycineGlycine--tRNA ligasetarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Atarget
DB00145GlycineBile acid-CoA:amino acid N-acyltransferasetarget
DB00145GlycineN-arachidonyl glycine receptortarget
DB00145GlycineGlutamate receptor ionotropic, NMDA 2Ctarget
DB00145GlycineSerine hydroxymethyltransferasetarget
DB00145GlycineGlycine N-acyltransferasetarget
DB00145GlycineProton-coupled amino acid transporter 1target
DB00145GlycineSerine hydroxymethyltransferase, mitochondrialtarget
DB00145GlycineGlycine N-acyltransferase-like protein 2target
DB00145GlycineGlycine N-acyltransferase-like protein 1target
DB00145GlycineAlanine--glyoxylate aminotransferase 2, mitochondrialtarget
DB00145GlycineVesicular inhibitory amino acid transportertarget
DB00145GlycinePeroxisomal sarcosine oxidasetarget
DB00145GlycineSodium- and chloride-dependent glycine transporter 2target
DB00145GlycineMonocarboxylate transporter 10transporter
DB00148CreatineSodium- and chloride-dependent creatine transporter 1target
DB00148CreatineGuanidinoacetate N-methyltransferasetarget
DB00148CreatineCreatine kinase M-typetarget
DB00148CreatineCreatine kinase U-type, mitochondrialtarget
DB00148CreatineCreatine kinase B-typetarget
DB00148CreatineCreatine kinase S-type, mitochondrialtarget
DB00148CreatineSolute carrier family 22 member 5transporter
DB00149L-LeucineProbable leucine--tRNA ligase, mitochondrialtarget
DB00149L-LeucineLeucine carboxyl methyltransferase 2target
DB00149L-LeucineLeucine carboxyl methyltransferase 1target
DB00149L-LeucineLeucine--tRNA ligase, cytoplasmictarget
DB00149L-LeucineBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00149L-LeucineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00149L-LeucineMonocarboxylate transporter 10transporter
DB00149L-LeucineMonocarboxylate transporter 8transporter
DB00150L-TryptophanTryptophan--tRNA ligase, cytoplasmictarget
DB00150L-TryptophanTryptophan--tRNA ligasetarget
DB00150L-TryptophanTryptophan--tRNA ligase, mitochondrialtarget
DB00150L-TryptophanTryptophan 2,3-dioxygenaseenzyme
DB00150L-TryptophanAromatic-L-amino-acid decarboxylaseenzyme
DB00150L-TryptophanMonocarboxylate transporter 8transporter
DB00150L-TryptophanMonocarboxylate transporter 10transporter
DB00150L-TryptophanTryptophan--tRNA ligaseenzyme
DB00150L-TryptophanTryptophan--tRNA ligase, mitochondrialenzyme
DB00150L-TryptophanTryptophan 5-hydroxylase 1enzyme
DB00150L-TryptophanTryptophan 5-hydroxylase 2enzyme
DB00150L-TryptophanTryptophan--tRNA ligase, cytoplasmicenzyme
DB00150L-TryptophanIndoleamine 2,3-dioxygenase 1enzyme
DB00151L-CysteineCysteine--tRNA ligase, cytoplasmictarget
DB00151L-CysteineGlutamate--cysteine ligase regulatory subunittarget
DB00151L-CysteineGlutamate--cysteine ligase catalytic subunittarget
DB00151L-CysteineAspartate aminotransferase, cytoplasmictarget
DB00151L-CysteineCystathionine gamma-lyasetarget
DB00151L-CysteineCystathionine beta-synthasetarget
DB00151L-CysteineCysteine dioxygenase type 1target
DB00151L-CysteineMethylated-DNA--protein-cysteine methyltransferasetarget
DB00151L-CysteineGlutathione synthetasetarget
DB00151L-CysteineThiamine transporter 2target
DB00151L-CysteineProbable cysteine--tRNA ligase, mitochondrialtarget
DB00151L-CysteineCysteine sulfinic acid decarboxylasetarget
DB00151L-CysteineCysteine desulfurase, mitochondrialtarget
DB00151L-CysteineMonocarboxylate transporter 10transporter
DB00155L-CitrullineNitric oxide synthase, endothelialtarget
DB00155L-CitrullineArgininosuccinate synthasetarget
DB00155L-CitrullineN(G),N(G)-dimethylarginine dimethylaminohydrolase 2target
DB00155L-CitrullineArgininosuccinate synthetase, isoform CRA_atarget
DB00155L-CitrullineN(G),N(G)-dimethylarginine dimethylaminohydrolase 1target
DB00155L-CitrullineOrnithine carbamoyltransferase, mitochondrialtarget
DB00155L-CitrullineNitric oxide synthase, braintarget
DB00155L-CitrullineNitric oxide synthase, inducibletarget
DB00155L-CitrullineProtein-arginine deiminase type-4target
DB00155L-CitrullineProtein-arginine deiminase type-6target
DB00155L-CitrullineProtein-arginine deiminase type-1target
DB00155L-CitrullineProtein-arginine deiminase type-3target
DB00155L-CitrullineProtein-arginine deiminase type-2target
DB00156L-ThreonineThreonine synthase-like 1target
DB00156L-ThreonineThreonine--tRNA ligase, cytoplasmictarget
DB00156L-ThreonineThreonine--tRNA ligase, mitochondrialtarget
DB00156L-ThreonineMonocarboxylate transporter 10transporter
DB00160L-AlanineSerine--pyruvate aminotransferasetarget
DB00160L-AlanineAlanine aminotransferase 1target
DB00160L-AlanineCysteine desulfurase, mitochondrialtarget
DB00160L-AlanineProton-coupled amino acid transporter 1target
DB00160L-AlanineLarge neutral amino acids transporter small subunit 2target
DB00160L-AlanineAlanine--glyoxylate aminotransferase 2, mitochondrialtarget
DB00160L-AlanineAlanine--tRNA ligase, cytoplasmictarget
DB00160L-AlanineNeutral amino acid transporter Atarget
DB00160L-Alanine4-aminobutyrate aminotransferase, mitochondrialtarget
DB00160L-AlanineKynureninasetarget
DB00160L-AlanineAlanine--tRNA ligase, mitochondrialtarget
DB00160L-Alanine5-phosphohydroxy-L-lysine phospho-lyasetarget
DB00160L-AlanineAlanine aminotransferase 2target
DB00160L-AlanineMonocarboxylate transporter 10transporter
DB00161L-ValinePropionyl-CoA carboxylase beta chain, mitochondrialtarget
DB00161L-ValineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00161L-ValineValine--tRNA ligasetarget
DB00161L-ValineMonocarboxylate transporter 10transporter
DB00161L-ValineValine--tRNA ligaseenzyme
DB00161L-ValinePropionyl-CoA carboxylase beta chain, mitochondrialenzyme
DB00161L-ValineBranched-chain-amino-acid aminotransferase, cytosolicenzyme
DB00167L-IsoleucineShort/branched chain specific acyl-CoA dehydrogenase, mitochondrialtarget
DB00167L-IsoleucineBranched-chain-amino-acid aminotransferase, cytosolictarget
DB00167L-IsoleucineBranched-chain-amino-acid aminotransferase, mitochondrialtarget
DB00167L-IsoleucineIsoleucine--tRNA ligase, cytoplasmictarget
DB00167L-IsoleucineIsoleucine--tRNA ligase, mitochondrialtarget
DB00167L-IsoleucineMonocarboxylate transporter 10transporter
DB00168AspartameTaste receptor type 1 member 2target
DB00168AspartameTransient receptor potential cation channel subfamily V member 1target
DB00168AspartameSolute carrier family 22 member 6transporter
DB00168AspartameSolute carrier family 22 member 8transporter
DB00168AspartameSolute carrier family 22 member 11transporter
DB00168AspartameTaste receptor type 1 member 3target
DB00172L-ProlinePyrroline-5-carboxylate reductase 1, mitochondrialtarget
DB00172L-ProlineBifunctional glutamate/proline--tRNA ligasetarget
DB00172L-ProlineSodium- and chloride-dependent neutral and basic amino acid transporter B(0+)target
DB00172L-ProlineSodium-dependent proline transportertarget
DB00172L-ProlinePyrroline-5-carboxylate reductase 2target
DB00172L-ProlineProlyl 4-hydroxylase subunit alpha-2target
DB00172L-ProlineProline dehydrogenase 1, mitochondrialtarget
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase Htarget
DB00172L-ProlineProline synthase co-transcribed bacterial homolog proteintarget
DB00172L-ProlineProlyl 4-hydroxylase subunit alpha-1target
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase Btarget
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase Ctarget
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase Atarget
DB00172L-ProlinePeptidyl-prolyl cis-trans isomerase Gtarget
DB00172L-ProlineProlyl 3-hydroxylase 1target
DB00172L-ProlinePyrroline-5-carboxylate reductasetarget
DB00172L-ProlineProbable proline--tRNA ligase, mitochondrialtarget
DB00172L-ProlineProlyl 3-hydroxylase 2target
DB00172L-ProlineProlyl 3-hydroxylase 3target
DB00172L-ProlinePyrroline-5-carboxylate reductase 3target
DB00172L-ProlineTrans-L-3-hydroxyproline dehydratasetarget
DB00172L-ProlineProline dehydrogenase 1, mitochondrialenzyme
DB00172L-ProlineMonocarboxylate transporter 10transporter
DB00174L-AsparagineNeutral amino acid transporter B(0)target
DB00174L-AsparagineAsparagine synthetase [glutamine-hydrolyzing]target
DB00174L-AsparagineAsparagine--tRNA ligase, cytoplasmictarget
DB00174L-AsparagineIsoaspartyl peptidase/L-asparaginasetarget
DB00174L-AsparagineProbable asparagine--tRNA ligase, mitochondrialtarget
DB00174L-AsparagineSodium-coupled neutral amino acid transporter 3target
DB00174L-AsparagineMonocarboxylate transporter 10transporter
DB00177ValsartanType-1 angiotensin II receptortarget
DB00177ValsartanCytochrome P450 2C9enzyme
DB00177ValsartanSolute carrier organic anion transporter family member 1B3transporter
DB00177ValsartanSolute carrier organic anion transporter family member 1B1transporter
DB00177ValsartanSerum albumincarrier
DB00181BaclofenGamma-aminobutyric acid type B receptor subunit 1target
DB00181BaclofenGamma-aminobutyric acid type B receptor subunit 2target
DB00181BaclofenSolute carrier family 22 member 8transporter
DB00183PentagastrinGastrin/cholecystokinin type B receptortarget
DB00183PentagastrinCholinesteraseenzyme
DB00190CarbidopaAromatic-L-amino-acid decarboxylasetarget
DB00230PregabalinVoltage-dependent P/Q-type calcium channel subunit alpha-1Atarget
DB00230PregabalinExcitatory amino acid transporter 3transporter
DB00260CycloserineD-alanine--D-alanine ligase Atarget
DB00260CycloserineAlanine racemasetarget
DB00260CycloserineAromatic-L-amino-acid decarboxylaseenzyme
DB00260CycloserineProton-coupled amino acid transporter 2transporter
DB00279LiothyronineThyroid hormone receptor betatarget
DB00279LiothyronineThyroid hormone receptor alphatarget
DB00279LiothyronineThyroxine-binding globulincarrier
DB00279LiothyronineTransthyretincarrier
DB00279LiothyronineSerum albumincarrier
DB00279LiothyronineMultidrug resistance protein 1transporter
DB00279LiothyronineSolute carrier family 22 member 8transporter
DB00279LiothyronineMonocarboxylate transporter 10transporter
DB00279LiothyronineSolute carrier organic anion transporter family member 4A1transporter
DB00279LiothyronineSolute carrier organic anion transporter family member 1C1transporter
DB00279LiothyronineSolute carrier organic anion transporter family member 1A2transporter
DB00279LiothyronineSodium/bile acid cotransportertransporter
DB00279LiothyronineSolute carrier organic anion transporter family member 4C1transporter
DB00279LiothyronineSolute carrier organic anion transporter family member 1B3transporter
DB00279LiothyronineSolute carrier organic anion transporter family member 1B1transporter
DB00279LiothyronineLarge neutral amino acids transporter small subunit 1transporter
DB00279LiothyronineProliferating cell nuclear antigentarget
DB00290BleomycinDNA ligase 3target
DB00290BleomycinDNA ligase 1target
DB00290BleomycinDNAtarget
DB00290BleomycinBleomycin hydrolaseenzyme
DB00314Capreomycin70S ribosometarget
DB00362Anidulafungin1,3-beta-glucan synthase component FKS1target
DB00403CeruletideCholecystokinin receptor type Atarget
DB00420PromazineD(2) dopamine receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M4target
DB00420PromazineMuscarinic acetylcholine receptor M2target
DB00420PromazineMuscarinic acetylcholine receptor M3target
DB00420PromazineAlpha-1B adrenergic receptortarget
DB00420PromazineD(1A) dopamine receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M5target
DB00420Promazine5-hydroxytryptamine receptor 2Atarget
DB00420Promazine5-hydroxytryptamine receptor 2Ctarget
DB00420PromazineAlpha-1A adrenergic receptortarget
DB00420PromazineMuscarinic acetylcholine receptor M1target
DB00420PromazineD(4) dopamine receptortarget
DB00420PromazineHistamine H1 receptortarget
DB00420PromazineAlpha-1D adrenergic receptortarget
DB00420PromazineCytochrome P450 2C19enzyme
DB00420PromazineCytochrome P450 1A2enzyme
DB00420PromazineCytochrome P450 3A4enzyme
DB00420PromazineCytochrome P450 2C9enzyme
DB00420PromazineCytochrome P450 2D6enzyme
DB00451LevothyroxineThyroid hormone receptor alphatarget
DB00451LevothyroxineThyroid hormone receptor betatarget
DB00451LevothyroxineCytochrome P450 2C8enzyme
DB00451LevothyroxineTransthyretincarrier
DB00451LevothyroxineSerum albumincarrier
DB00451LevothyroxineThyroxine-binding globulincarrier
DB00451LevothyroxineMultidrug resistance protein 1transporter
DB00451LevothyroxineMonocarboxylate transporter 8transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1C1transporter
DB00451LevothyroxineCytochrome P450 3A4enzyme
DB00451LevothyroxineSolute carrier organic anion transporter family member 1A2transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1B1transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 1B3transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 4A1transporter
DB00451LevothyroxineSolute carrier organic anion transporter family member 4C1transporter
DB00451LevothyroxineLarge neutral amino acids transporter small subunit 1transporter
DB00492FosinoprilAngiotensin-converting enzymetarget
DB00492FosinoprilSolute carrier family 15 member 1transporter
DB00492FosinoprilSolute carrier family 15 member 2transporter
DB00509DextrothyroxineThyroid hormone receptor alphatarget
DB00509DextrothyroxineThyroid hormone receptor betatarget
DB00509DextrothyroxineThyroid peroxidasetarget
DB00509DextrothyroxineSolute carrier organic anion transporter family member 1B1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 1C1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 4A1transporter
DB00509DextrothyroxineSolute carrier organic anion transporter family member 4C1transporter
DB00509DextrothyroxineLarge neutral amino acids transporter small subunit 1transporter
DB00512VancomycinD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DB00512VancomycinSerum albumincarrier
DB00512Vancomycinalpha1-acid glycoproteincarrier
DB00512VancomycinGamma Globulincarrier
DB00513Aminocaproic AcidPlasminogentarget
DB00513Aminocaproic AcidTissue-type plasminogen activatortarget
DB00513Aminocaproic AcidApolipoprotein(a)target
DB00513Aminocaproic AcidAldehyde oxidaseenzyme
DB00520CaspofunginSolute carrier family 22 member 1transporter
DB00520CaspofunginMultidrug resistance protein 1transporter
DB00520CaspofunginSolute carrier family 22 member 6transporter
DB00520CaspofunginSolute carrier organic anion transporter family member 1B1transporter
DB00520CaspofunginSolute carrier organic anion transporter family member 1B3transporter
DB00520CaspofunginCytochrome P450 3A4enzyme
DB00520Caspofungin1,3-beta-glucan synthase component FKS1target
DB00577ValaciclovirThymidine kinasetarget
DB00577ValaciclovirDNA polymerase catalytic subunittarget
DB00577ValaciclovirSolute carrier family 15 member 1transporter
DB00577ValaciclovirSolute carrier family 15 member 2transporter
DB00577ValaciclovirSolute carrier family 22 member 8transporter
DB00577ValaciclovirSolute carrier family 22 member 6transporter
DB00577ValaciclovirSodium- and chloride-dependent neutral and basic amino acid transporter B(0+)transporter
DB00577ValaciclovirIleal sodium/bile acid cotransportertransporter
DB00577ValaciclovirCytochrome P450 1A2enzyme
DB00584EnalaprilAngiotensin-converting enzymetarget
DB00584EnalaprilCytochrome P450 3A4enzyme
DB00584EnalaprilMultidrug resistance protein 1transporter
DB00584EnalaprilSolute carrier family 15 member 1transporter
DB00584EnalaprilSolute carrier family 22 member 6transporter
DB00584EnalaprilSolute carrier family 22 member 8transporter
DB00584EnalaprilSolute carrier family 22 member 7transporter
DB00584EnalaprilSolute carrier organic anion transporter family member 1A2transporter
DB00626BacitracinAlpha-2-macroglobulintarget
DB00626BacitracinInsulin-degrading enzymetarget
DB00626BacitracinC55-isoprenyl pyrophosphatetarget
DB00642PemetrexedThymidylate synthasetarget
DB00642PemetrexedDihydrofolate reductasetarget
DB00642PemetrexedTrifunctional purine biosynthetic protein adenosine-3target
DB00642PemetrexedDeoxycytidine kinaseenzyme
DB00642PemetrexedBifunctional purine biosynthesis protein PURHtarget
DB00642PemetrexedEquilibrative nucleoside transporter 1enzyme
DB00644GonadorelinGonadotropin-releasing hormone receptortarget
DB00644GonadorelinPutative gonadotropin-releasing hormone II receptortarget
DB00666NafarelinGonadotropin-releasing hormone receptortarget
DB00666NafarelinPutative gonadotropin-releasing hormone II receptortarget
DB00722LisinoprilAngiotensin-converting enzymetarget
DB00731NateglinideATP-binding cassette sub-family C member 8target
DB00731NateglinideCytochrome P450 3A4enzyme
DB00731NateglinideCytochrome P450 2C9enzyme
DB00731NateglinidePeroxisome proliferator-activated receptor gammatarget
DB00731NateglinideCytochrome P450 3A5enzyme
DB00731NateglinideCytochrome P450 3A7enzyme
DB00731NateglinideSolute carrier family 15 member 1transporter
DB00731NateglinideSolute carrier family 15 member 2transporter
DB00731NateglinideSolute carrier family 22 member 6transporter
DB00731NateglinideMonocarboxylate transporter 1transporter
DB00731NateglinideProstaglandin G/H synthase 1enzyme
DB00731NateglinideUDP-glucuronosyltransferase 1-9enzyme
DB00731NateglinideCytochrome P450 2D6enzyme
DB00731NateglinideMultidrug resistance-associated protein 4transporter
DB00731NateglinideSerum albumincarrier
DB00731NateglinideAlpha-1-acid glycoprotein 1carrier
DB00765MetyrosineTyrosine 3-monooxygenasetarget
DB00775TirofibanIntegrin alpha-IIbtarget
DB00775TirofibanIntegrin beta-3target
DB00781Polymyxin B SulfateBacterial outer membranetarget
DB00803ColistinBacterial outer membranetarget
DB00837ProgabideGamma-aminobutyric acid receptor subunit alpha-1target
DB00837ProgabideGamma-aminobutyric acid type B receptor subunit 1target
DB00855Aminolevulinic acidDelta-aminolevulinic acid dehydratasetarget
DB00855Aminolevulinic acidSolute carrier family 15 member 1transporter
DB00855Aminolevulinic acidSolute carrier family 15 member 2transporter
DB00859PenicillamineSolute carrier organic anion transporter family member 1B1transporter
DB00859PenicillamineCoppertarget
DB00968MethyldopaAlpha-2A adrenergic receptortarget
DB00968MethyldopaCatechol O-methyltransferaseenzyme
DB00968MethyldopaSolute carrier family 15 member 1transporter
DB00968MethyldopaAromatic-L-amino-acid decarboxylasetarget
DB00970DactinomycinDNAtarget
DB00970DactinomycinSolute carrier family 22 member 5transporter
DB00970DactinomycinMultidrug resistance protein 1transporter
DB00970DactinomycinMultidrug resistance-associated protein 6transporter
DB00970DactinomycinMultidrug resistance-associated protein 1transporter
DB00970DactinomycinATP-binding cassette sub-family G member 2transporter
DB00970DactinomycinDNA topoisomerase 2target
DB00992Methyl aminolevulinateHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00996GabapentinAdenosine receptor A1target
DB00996GabapentinVoltage-dependent N-type calcium channel subunit alpha-1Btarget
DB00996GabapentinVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB00996GabapentinVoltage-dependent calcium channel subunit alpha-2/delta-2target
DB00996GabapentinBranched-chain-amino-acid aminotransferase, cytosolicenzyme
DB00996GabapentinNMDA receptortarget
DB00996GabapentinGamma-aminobutyric acid type B receptor subunit 1target
DB00996GabapentinGamma-aminobutyric acid type B receptor subunit 2target
DB01042MelphalanDNAtarget
DB01042MelphalanSolute carrier family 22 member 3transporter
DB01042MelphalanLarge neutral amino acids transporter small subunit 1transporter
DB01055MimosineSerine hydroxymethyltransferase, cytosolictarget
DB01055MimosineC-C motif chemokine 2target
DB01055MimosineTyrosinasetarget
DB01072AtazanavirHuman immunodeficiency virus type 1 proteasetarget
DB01072AtazanavirCytochrome P450 3A4enzyme
DB01072AtazanavirCytochrome P450 2C9enzyme
DB01072AtazanavirMultidrug resistance protein 1transporter
DB01072AtazanavirMultidrug resistance-associated protein 1transporter
DB01072AtazanavirCytochrome P450 1A2enzyme
DB01072AtazanavirSerum albumincarrier
DB01080Vigabatrin4-aminobutyrate aminotransferase, mitochondrialtarget
DB01080VigabatrinGamma-aminobutyric acid type B receptor subunit 1target
DB01080VigabatrinProton-coupled amino acid transporter 1transporter
DB01111ColistimethateBacterial outer membranetarget
DB01141MicafunginArylsulfatase Aenzyme
DB01141MicafunginCatechol O-methyltransferaseenzyme
DB01141Micafungin1,3-beta-glucan synthase component FKS1target
DB01197CaptoprilAngiotensin-converting enzymetarget
DB01197CaptoprilCytochrome P450 2D6enzyme
DB01197CaptoprilSerum albumincarrier
DB01197Captopril72 kDa type IV collagenasetarget
DB01197CaptoprilMatrix metalloproteinase-9target
DB01197CaptoprilMultidrug resistance protein 1transporter
DB01197CaptoprilSolute carrier family 15 member 1transporter
DB01197CaptoprilSolute carrier family 22 member 6transporter
DB01197CaptoprilLeukotriene A-4 hydrolasetarget
DB01197CaptoprilB1 bradykinin receptortarget
DB01221KetamineGlutamate receptor ionotropic, NMDA 3Atarget
DB01221KetamineSubstance-P receptortarget
DB01221KetamineCytochrome P450 2B6enzyme
DB01221KetamineCytochrome P450 2C9enzyme
DB01221KetamineCytochrome P450 3A4enzyme
DB01221KetamineD(2) dopamine receptortarget
DB01221KetamineMultidrug resistance protein 1transporter
DB01221KetamineProstaglandin G/H synthase 1enzyme
DB01221KetamineCytochrome P450 2C8enzyme
DB01221KetamineDelta-type opioid receptortarget
DB01221KetamineSodium-dependent noradrenaline transportertarget
DB01221KetamineKappa-type opioid receptortarget
DB01221KetamineMu-type opioid receptortarget
DB01221KetamineMuscarinic acetylcholine receptortarget
DB01221Ketamine5-hydroxytryptamine receptor 2target
DB01221Ketamine5-hydroxytryptamine receptor 1target
DB01229PaclitaxelApoptosis regulator Bcl-2target
DB01229PaclitaxelTubulin beta-1 chaintarget
DB01229PaclitaxelCytochrome P450 2C8enzyme
DB01229PaclitaxelCytochrome P450 3A4enzyme
DB01229PaclitaxelCytochrome P450 3A5enzyme
DB01229PaclitaxelCytochrome P450 3A7enzyme
DB01229PaclitaxelCytochrome P450 2C9enzyme
DB01229PaclitaxelBile salt export pumptransporter
DB01229PaclitaxelMultidrug resistance protein 1transporter
DB01229PaclitaxelMultidrug resistance-associated protein 1transporter
DB01229PaclitaxelMultidrug resistance-associated protein 7transporter
DB01229PaclitaxelCytochrome P450 19A1enzyme
DB01229PaclitaxelCytochrome P450 1B1enzyme
DB01229PaclitaxelSolute carrier organic anion transporter family member 1B3transporter
DB01229PaclitaxelNuclear receptor subfamily 1 group I member 2target
DB01229PaclitaxelMicrotubule-associated protein 4target
DB01229PaclitaxelMicrotubule-associated protein 2target
DB01229PaclitaxelMicrotubule-associated protein tautarget
DB01229PaclitaxelATP-binding cassette sub-family G member 2transporter
DB01229PaclitaxelCanalicular multispecific organic anion transporter 1transporter
DB01235LevodopaD(1A) dopamine receptortarget
DB01235LevodopaD(2) dopamine receptortarget
DB01235LevodopaAromatic-L-amino-acid decarboxylaseenzyme
DB01235LevodopaSolute carrier family 15 member 1transporter
DB01235LevodopaMonocarboxylate transporter 10transporter
DB01235LevodopaD(3) dopamine receptortarget
DB01235LevodopaD(4) dopamine receptortarget
DB01235LevodopaD(1B) dopamine receptortarget
DB01235LevodopaCytochrome P450 2D6enzyme
DB01235LevodopaLarge neutral amino acids transporter small subunit 1transporter
DB01235LevodopaLarge neutral amino acids transporter small subunit 2transporter
DB01257EculizumabComplement C5target
DB01269PanitumumabEpidermal growth factor receptortarget
DB01270RanibizumabVascular endothelial growth factor Atarget
DB01276ExenatideGlucagon-like peptide 1 receptortarget
DB01276ExenatideSerum albumincarrier
DB01277MecaserminInsulin-like growth factor 1 receptortarget
DB01277MecaserminInsulin-like growth factor-binding protein 3target
DB01277MecaserminInsulin receptortarget
DB01277MecaserminCation-independent mannose-6-phosphate receptortarget
DB01278PramlintideReceptor activity-modifying protein 1target
DB01278PramlintideReceptor activity-modifying protein 2target
DB01278PramlintideReceptor activity-modifying protein 3target
DB01278PramlintideCalcitonin receptortarget
DB01279GalsulfasePerilipin-3target
DB01279GalsulfaseDermatan sulfatetarget
DB01281AbataceptT-lymphocyte activation antigen CD80target
DB01281AbataceptT-lymphocyte activation antigen CD86target
DB01282CarbetocinOxytocin receptortarget
DB01284TetracosactideAdrenocorticotropic hormone receptortarget
DB01285CorticotropinAdrenocorticotropic hormone receptortarget
DB01285CorticotropinCorticoliberintarget
DB01285Corticotropin3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
DB01285Corticotropin25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialenzyme
DB01285Corticotropin1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialenzyme
DB01306Insulin AspartInsulin receptortarget
DB01306Insulin AspartCytochrome P450 1A2enzyme
DB01307Insulin DetemirInsulin receptortarget
DB01307Insulin DetemirSerum albumincarrier
DB01307Insulin DetemirCytochrome P450 1A2enzyme
DB01309Insulin GlulisineInsulin receptortarget
DB01309Insulin GlulisineCytochrome P450 1A2enzyme
DB01348SpiraprilAngiotensin-converting enzymetarget
DB01348SpiraprilSolute carrier family 15 member 1transporter
DB01348SpiraprilSolute carrier family 15 member 2transporter
DB01369Quinupristin23S rRNAtarget
DB01369Quinupristin50S ribosomal protein L10target
DB01369Quinupristin50S ribosomal protein L22target
DB01369QuinupristinCytochrome P450 3A4enzyme
DB01373CalciumProtein S100-Btarget
DB01373CalciumCalpastatintarget
DB01373CalciumCartilage oligomeric matrix proteintarget
DB01373CalciumCalmodulintarget
DB01373CalciumSpectrin beta chain, non-erythrocytic 1target
DB01373CalciumVoltage-dependent L-type calcium channel subunit alpha-1Ctarget
DB01373CalciumTroponin C, skeletal muscletarget
DB01373CalciumTroponin C, slow skeletal and cardiac musclestarget
DB01373CalciumCalcium-transporting ATPase type 2C member 1target
DB01373CalciumAmiloride-sensitive amine oxidase [copper-containing]target
DB01373CalciumProtein S100-A13target
DB01373CalciumAlkaline phosphatase, placental typetarget
DB01373CalciumProtein S100-A8target
DB01373CalciumProtein S100-A9target
DB01373CalciumProtein S100-A2target
DB01373CalciumCeruloplasmintarget
DB01373CalciumBone morphogenetic protein 4target
DB01373CalciumMatrix Gla proteintarget
DB01373CalciumProtocadherin-19target
DB01373CalciumProgrammed cell death protein 6target
DB01583LiotrixThyroid hormone receptor alphatarget
DB01583LiotrixThyroid hormone receptor betatarget
DB01583LiotrixCytochrome P450 2C8enzyme
DB01583LiotrixSolute carrier organic anion transporter family member 1A2transporter
DB01583LiotrixSolute carrier organic anion transporter family member 1B1transporter
DB01583LiotrixSolute carrier organic anion transporter family member 1B3transporter
DB01583LiotrixSolute carrier organic anion transporter family member 4C1transporter
DB01583LiotrixSodium/bile acid cotransportertransporter
DB01583LiotrixSolute carrier organic anion transporter family member 1C1transporter
DB01583LiotrixSolute carrier organic anion transporter family member 4A1transporter
DB01583LiotrixSolute carrier family 22 member 8transporter
DB01583LiotrixMonocarboxylate transporter 8transporter
DB01583LiotrixMonocarboxylate transporter 10transporter
DB01583LiotrixMultidrug resistance protein 1transporter
DB01583LiotrixTransthyretincarrier
DB01583LiotrixThyroxine-binding globulincarrier
DB01583LiotrixSerum albumincarrier
DB01646N-AcetylmethionineN-acylamino acid racemasetarget
DB01646N-AcetylmethionineRhodopsintarget
DB01669Virginiamycin M1Streptogramin A acetyltransferasetarget
DB01683ChymostatinPeptide amidasetarget
DB01686N,N-dimethylarginineNitric oxide synthase, inducibletarget
DB01686N,N-dimethylarginineNitric oxide synthase, endothelialtarget
DB01764DalfopristinStreptogramin A acetyltransferasetarget
DB01764DalfopristinCytochrome P450 3A4enzyme
DB01783Pantothenic acidPantothenate kinasetarget
DB01853Bacteriochlorophyll ABacteriochlorophyll a proteintarget
DB01853Bacteriochlorophyll ABacteriochlorophyll a proteintarget
DB02011N-(Phosphonoacetyl)-L-OrnithineOrnithine carbamoyltransferase, mitochondrialtarget
DB02083N,N-dimethylglycineMonomeric sarcosine oxidasetarget
DB02109HadacidinAdenylosuccinate synthetasetarget
DB02109HadacidinAdenylosuccinate synthetase isozyme 1target
DB02109HadacidinAdenylosuccinate synthetasetarget
DB02123Glycochenodeoxycholic Acid7-alpha-hydroxysteroid dehydrogenasetarget
DB02123Glycochenodeoxycholic AcidBile salt export pumptransporter
DB02123Glycochenodeoxycholic AcidSolute carrier organic anion transporter family member 1A2transporter
DB02123Glycochenodeoxycholic AcidIleal sodium/bile acid cotransportertransporter
DB02123Glycochenodeoxycholic AcidSodium/bile acid cotransportertransporter
DB02137Molybdenum CofactorAldehyde oxidoreductasetarget
DB02174D-GlutamineGlutamate racemasetarget
DB02216S-MethylcysteineCathepsin Dtarget
DB02216S-MethylcysteineFatty acid-binding protein, livercarrier
DB02216S-MethylcysteineMethylated-DNA--protein-cysteine methyltransferasetarget
DB02235L-methionine (R)-S-oxideCatalasetarget
DB02235L-methionine (R)-S-oxideProteasetarget
DB02235L-methionine (R)-S-oxideAmyloid beta A4 proteintarget
DB02236Glycinamide RibonucleotidePhosphoribosylglycinamide formyltransferase 2target
DB02236Glycinamide RibonucleotidePhosphoribosylglycinamide formyltransferasetarget
DB02236Glycinamide RibonucleotideTrifunctional purine biosynthetic protein adenosine-3target
DB02255GM6001Lethal factortarget
DB02255GM6001Disintegrin and metalloproteinase domain-containing protein 28target
DB02255GM6001Aggrecan core proteintarget
DB02261Platelet Activating FactorGanglioside GM2 activatortarget
DB02261Platelet Activating FactorMultidrug resistance protein 1transporter
DB02261Platelet Activating FactorPlatelet-activating factor receptortarget
DB022747-Keto-8-Aminopelargonic AcidAdenosylmethionine-8-amino-7-oxononanoate aminotransferasetarget
DB02307N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-AsparaginePseudolysintarget
DB02341Mdl 101,146Chymotrypsin-like elastase family member 1target
DB02341Mdl 101,146Neutrophil elastasetarget
DB02345SelenocysteineCathelicidin antimicrobial peptidetarget
DB02345SelenocysteineNucleoside diphosphate kinase Atarget
DB02345SelenocysteineFormate dehydrogenase Htarget
DB02345SelenocysteineCysteine desulfurasetarget
DB02386Leucine Phosphonic AcidBacterial leucyl aminopeptidasetarget
DB02386Leucine Phosphonic AcidCytosol aminopeptidasetarget
DB02518N-AcetylalanineAldose reductasetarget
DB02543Pyrrole-2-CarboxylateMonomeric sarcosine oxidasetarget
DB02557PhosphoramidonNeprilysintarget
DB02557PhosphoramidonKell blood group glycoproteintarget
DB02578Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-AlanineD-alanyl-D-alanine carboxypeptidasetarget
DB02595Bulgecin AMembrane-bound lytic murein transglycosylase Btarget
DB02595Bulgecin ASoluble lytic murein transglycosylasetarget
DB02608N-Acetyl-P-NitrophenylserinolChloramphenicol 3-O phosphotransferasetarget
DB02638TerlipressinVasopressin V1a receptortarget
DB02638TerlipressinVasopressin V2 receptortarget
DB02638TerlipressinVasopressin V1b receptortarget
DB02655D-Aspartic AcidThermolysintarget
DB02655D-Aspartic AcidL-asparaginasetarget
DB02810N-(2-Acetamido)Iminodiacetic AcidPeptide deformylasetarget
DB02821CanalineOrnithine aminotransferase, mitochondrialtarget
DB02855N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineCathepsin Btarget
DB02952Alpha-Aminoisobutyric AcidCorticoliberintarget
DB02952Alpha-Aminoisobutyric AcidPro-neuropeptide Ytarget
DB02952Alpha-Aminoisobutyric AcidMonocarboxylate transporter 10transporter
DB02959OxitriptanTryptophan--tRNA ligase 2target
DB02975GE-2270AElongation factor Tutarget
DB02999QuisqualateGlutamate receptor 2target
DB02999QuisqualateGlutamate receptor ionotropic, kainate 2target
DB03032S-OctylglutathioneGlutathione S-transferase Mu 4target
DB03088Pidolic AcidAlpha-amylase 2Btarget
DB03088Pidolic AcidAngiogenintarget
DB03088Pidolic AcidChondroitinase-Btarget
DB03088Pidolic AcidAlpha-amylase 1target
DB03088Pidolic AcidVascular endothelial growth factor Atarget
DB03088Pidolic AcidPancreatic alpha-amylasetarget
DB03088Pidolic AcidIg lambda-1 chain C regionstarget
DB03088Pidolic AcidIg lambda chain V-II region MGCtarget
DB03088Pidolic AcidTrefoil factor 2target
DB03088Pidolic AcidCytochrome c2target
DB03088Pidolic AcidDisintegrin and metalloproteinase domain-containing protein 28target
DB03088Pidolic AcidEndo-1,4-beta-xylanasetarget
DB03088Pidolic AcidDissimilatory copper-containing nitrite reductasetarget
DB03088Pidolic AcidKeratin-associated protein 5-2target
DB03088Pidolic AcidOrexintarget
DB03088Pidolic AcidC-C motif chemokine 8target
DB03088Pidolic AcidCytochrome c'target
DB03088Pidolic AcidPancreatic alpha-amylaseenzyme
DB03107Beta-AlaninePantothenate synthetasetarget
DB03107Beta-AlanineMonocarboxylate transporter 10transporter
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, endothelialtarget
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase oxygenasetarget
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, inducibletarget
DB03144N-Omega-Hydroxy-L-ArginineArginase-1target
DB03144N-Omega-Hydroxy-L-ArginineNitric oxide synthase, braintarget
DB03157N,O-Didansyl-L-TyrosineThymidylate synthasetarget
DB03214VinylglycineL-amino-acid oxidasetarget
DB03214Vinylglycine1-aminocyclopropane-1-carboxylate synthase-like protein 1target
DB03223DiphthamideElongation factor 2target
DB03251RWJ-51084Trypsin-1target
DB03360N-Acetylproline(5R)-carbapenem-3-carboxylate synthasetarget
DB03380L-TyrosinamidePro-neuropeptide Ytarget
DB03380L-TyrosinamideValacyclovir hydrolasetarget
DB03395EnalkirenRenintarget
DB03408gamma-GlutamylcysteineGlutathione synthetasetarget
DB03424UbenimexBacterial leucyl aminopeptidasetarget
DB03424UbenimexLeukotriene A-4 hydrolasetarget
DB03424UbenimexSolute carrier family 15 member 1transporter
DB03424UbenimexSolute carrier family 15 member 2transporter
DB034252s,4r-4-MethylglutamateGlutamate receptor ionotropic, kainate 2target
DB03436GallichromeIron(3+)-hydroxamate-binding protein FhuDtarget
DB03459Sparfosic acidAspartate carbamoyltransferase catalytic chaintarget
DB03459Sparfosic acidCAD proteintarget
DB03470TrypanothioneTrypanothione reductasetarget
DB03535Z-Pro-ProlinalProlyl endopeptidasetarget
DB03535Z-Pro-ProlinalProlyl endopeptidasetarget
DB03544S-PhosphocysteineN,N'-diacetylchitobiose-specific phosphotransferase enzyme IIB componenttarget
DB03544S-PhosphocysteineEnamine/imine deaminasetarget
DB035523-TyrosineTyrosine 3-monooxygenasetarget
DB03632ArgifinChitotriosidase-1target
DB03632ArgifinChitinasetarget
DB03640Beta-Hydroxyaspartic AcidBeta-lactamase TEMtarget
DB036604-Iodo-L-phenylalanineLysozymetarget
DB036604-Iodo-L-phenylalaninePseudomonalisintarget
DB036604-Iodo-L-phenylalanineDipeptidyl peptidase 4target
DB036604-Iodo-L-phenylalanineAminopeptidase Starget
DB03709BicinePlasminogentarget
DB03709BicineMembrane-bound lytic murein transglycosylase Btarget
DB03709BicineUDP-galactopyranose mutasetarget
DB03799TrifluoromethionineMethionine--tRNA ligasetarget
DB03799TrifluoromethionineMethionine aminopeptidasetarget
DB038172,4-Diaminobutyric AcidEnvelope glycoprotein gp160target
DB03880BatimastatNeutrophil collagenasetarget
DB03880BatimastatMacrophage metalloelastasetarget
DB03880BatimastatMatrix metalloproteinase-16target
DB03880BatimastatDisintegrin and metalloproteinase domain-containing protein 28target
DB03880BatimastatA disintegrin and metalloproteinase with thrombospondin motifs 5target
DB03889S-(N-Hydroxy-N-Bromophenylcarbamoyl)GlutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
DB03940Oxamic AcidL-lactate dehydrogenasetarget
DB03940Oxamic AcidL-lactate dehydrogenasetarget
DB03940Oxamic AcidL-lactate dehydrogenase A chaintarget
DB03940Oxamic AcidL-lactate dehydrogenase B chaintarget
DB03940Oxamic AcidFormate acetyltransferase 1target
DB03940Oxamic AcidD-lactate dehydrogenasetarget
DB03940Oxamic AcidMonocarboxylate transporter 4transporter
DB04029Phenylalanine AmideGenome polyproteintarget
DB04029Phenylalanine AmideGenome polyproteintarget
DB04029Phenylalanine AmideD-Amino acid amidasetarget
DB04092ApstatinXaa-Pro aminopeptidasetarget
DB04129WillardiineGlutamate receptor 2target
DB04132S-HexylglutathioneLactoylglutathione lyasetarget
DB04132S-HexylglutathioneGlutathione S-transferase Mu 4target
DB04132S-HexylglutathioneGlutathione S-transferase Ptarget
DB04132S-HexylglutathioneGlutathione S-transferasetarget
DB04132S-HexylglutathioneGlutathione S-transferase A1target
DB04132S-HexylglutathioneGlutathione S-transferase theta-2target
DB04132S-HexylglutathioneGlutathione S-transferase A1enzyme
DB04167AceglutamideN-acylamino acid racemasetarget
DB04185NorvalineGlycine amidinotransferase, mitochondrialtarget
DB04185NorvalineOrnithine carbamoyltransferase, mitochondrialtarget
DB04191Skf 107457Gag-Pol polyproteintarget
DB04217L-2-amino-3-butynoic acidCysteine desulfurasetarget
DB04217L-2-amino-3-butynoic acidCystathionine gamma-lyasetarget
DB04223NitroarginineNitric oxide synthase, endothelialtarget
DB04223NitroarginineNitric oxide synthase, braintarget
DB04269Cyclotheonamide ATrypsin-1target
DB04284L-proline betaineGlycine betaine-binding periplasmic proteintarget
DB043346-hydroxydopa quinoneMembrane primary amine oxidasetarget
DB043346-hydroxydopa quinonePrimary amine oxidasetarget
DB043346-hydroxydopa quinonePhenylethylamine oxidasetarget
DB04339CarbocisteineGlutathione S-transferase Ptarget
DB04350ArgadinChitotriosidase-1target
DB04350ArgadinChitinasetarget
DB04391Aeruginosin 98-BTrypsin-1target
DB04418Adenylosuccinic AcidAdenylosuccinate synthetase isozyme 1target
DB044363-FluorotyrosineSuperoxide dismutase [Mn], mitochondrialtarget
DB04454Alpha-Aminobutyric AcidGlycine amidinotransferase, mitochondrialtarget
DB04454Alpha-Aminobutyric AcidGag-Pol polyproteintarget
DB04454Alpha-Aminobutyric AcidPro-epidermal growth factortarget
DB04454Alpha-Aminobutyric AcidLantibiotic mersacidintarget
DB04464N-FormylmethionineGlutamate--cysteine ligasetarget
DB04464N-FormylmethionineRibonuclease pancreatictarget
DB04464N-FormylmethioninePutative ATP-dependent Clp protease proteolytic subunit, mitochondrialtarget
DB04464N-FormylmethionineGeranylgeranyl transferase type-2 subunit alphatarget
DB04464N-FormylmethionineGeranylgeranyl transferase type-2 subunit betatarget
DB04464N-FormylmethioninePhotosynthetic reaction center cytochrome c subunittarget
DB04464N-FormylmethionineReaction center protein H chaintarget
DB04464N-FormylmethionineReaction center protein L chaintarget
DB04464N-FormylmethionineReaction center protein M chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/820 alpha chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/820 beta chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/850 alpha chaintarget
DB04464N-FormylmethionineLight-harvesting protein B-800/850 beta chaintarget
DB04464N-FormylmethionineAntithrombin-IIItarget
DB04464N-FormylmethionineBeta-2-microglobulintarget
DB04464N-FormylmethionineNADH-ubiquinone oxidoreductase chain 1target
DB04464N-FormylmethionineHLA class I histocompatibility antigen, B-27 alpha chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 alpha chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 beta chaintarget
DB04464N-FormylmethionineRespiratory nitrate reductase 1 gamma chaintarget
DB04464N-FormylmethionineProtein S100-Gtarget
DB04464N-FormylmethionineRubredoxintarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 4 isoform 1, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 1target
DB04464N-FormylmethionineCytochrome c oxidase subunit 2target
DB04464N-FormylmethionineCytochrome c oxidase subunit 3target
DB04464N-FormylmethionineCytochrome c oxidase subunit 5A, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 5B, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6Ctarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 7B, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 7C, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 8A, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6A2, mitochondrialtarget
DB04464N-FormylmethionineCytochrome c oxidase subunit 6B1target
DB04464N-FormylmethionineCytochrome c oxidase subunit 7A1, mitochondrialtarget
DB04464N-FormylmethionineMethionyl-tRNA formyltransferasetarget
DB04464N-FormylmethionineStreptavidintarget
DB04464N-FormylmethionineProtein S100-Btarget
DB04464N-FormylmethionineDelta-hemolysintarget
DB04464N-FormylmethioninePolyubiquitin-Ctarget
DB04464N-FormylmethionineAtpHtarget
DB04464N-FormylmethionineProbable L-ascorbate-6-phosphate lactonase UlaGtarget
DB04464N-FormylmethionineImmunoglobulin G-binding protein Gtarget
DB04495RU81843Proto-oncogene tyrosine-protein kinase Srctarget
DB04498Aspartate SemialdehydeAspartate-semialdehyde dehydrogenasetarget
DB04527Beta-HydroxyasparagineMannan-binding lectin serine protease 2target
DB04539Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
DB04539Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
DB04539GlyphosateCytochrome P450 19A1target
DB04539GlyphosateSerum albumincarrier
DB04620CycloleucineGlutamate receptor ionotropic, NMDA 1target
DB04676DansyllysineIg alpha-2 chain C regiontarget
DB04738MotuporinSerine/threonine-protein phosphatase PP1-gamma catalytic subunittarget
DB04798THIO-ATPAGlutamate receptor 2target
DB04805Virginiamycin S160S ribosomal protein L37target
DB04847RoxadustatEgl nine homolog 1target
DB04847RoxadustatEgl nine homolog 2target
DB04847RoxadustatEgl nine homolog 3target
DB04869OlcegepantCalcitonin gene-related peptide 1target
DB04869OlcegepantCalcitonin gene-related peptide type 1 receptortarget
DB04894VapreotideSubstance-P receptortarget
DB04894VapreotideSomatostatin receptor type 2target
DB04894VapreotideSomatostatin receptor type 5target
DB04899NesiritideAtrial natriuretic peptide receptor 1target
DB04899NesiritideAtrial natriuretic peptide receptor 2target
DB04899NesiritideAtrial natriuretic peptide receptor 3target
DB04901GaliximabT-lymphocyte activation antigen CD80target
DB04911OritavancinCytochrome P450 3A4enzyme
DB04925DesmoteplasePlasminogentarget
DB04931AfamelanotideMelanocyte-stimulating hormone receptortarget
DB04956AfelimomabTumor necrosis factortarget
DB04958EpratuzumabB-cell receptor CD22target
DB04964OregovomabMucin-16target
DB04972CanfosfamideGlutathione S-transferase Ptarget
DB04977PlitidepsinCytochrome P450 3A4enzyme
DB04977PlitidepsinCytochrome P450 2A6enzyme
DB04977PlitidepsinCytochrome P450 2E1enzyme
DB04977PlitidepsinCytochrome P450 4A11enzyme
DB04985Tigapotide40S ribosomal protein SAtarget
DB04988IGN311Epidermal growth factor receptortarget
DB04988IGN311Receptor tyrosine-protein kinase erbB-2target
DB05012XEN2174Sodium-dependent noradrenaline transportertarget
DB05029LancovutideCytosolic phospholipase A2enzyme
DB05032REV131Histamine H4 receptortarget
DB05034UlaritideAtrial natriuretic peptide receptor 1target
DB05084AbaloparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05092CDP323Integrin alpha-4target
DB05096LY2140023Metabotropic glutamate receptor 2target
DB05096LY2140023Metabotropic glutamate receptor 3target
DB05097LabetuzumabCarcinoembryonic antigentarget
DB05098LeptinLeptin receptortarget
DB05101MatuzumabEpidermal growth factor receptortarget
DB05111FontolizumabInterferon gammatarget
DB05115NN344Insulin receptortarget
DB05130INCB3284C-C chemokine receptor type 2target
DB05139CR002Platelet-derived growth factor Dtarget
DB05155CR665Kappa-type opioid receptortarget
DB05161ElafinNeutrophil elastasetarget
DB05161ElafinMyeloblastintarget
DB05161ElafinMyeloperoxidaseenzyme
DB05199LX1031Tryptophan 5-hydroxylase 1target
DB05209SYM001Rhesus blood group D antigentarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit alphatarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit betatarget
DB05210SF1126Phosphatidylinositol 3-kinase regulatory subunit gammatarget
DB05210SF1126DNA-dependent protein kinase catalytic subunittarget
DB05210SF1126Serine/threonine-protein kinase mTORtarget
DB05258Natural alpha interferonInterferon alpha/beta receptor 1target
DB05259Glatiramer AcetateHLA class II histocompatibility antigen, DRB1-1 beta chaintarget
DB05276Hepatitis B Immune GlobulinHBsAgtarget
DB05299keyhole limpet hemocyaninInterleukin-2target
DB05305Cintredekin BesudotoxInterleukin-13target
DB05311EcallantidePlasma kallikreintarget
DB05319oportuzumab monatoxEpithelial cell adhesion moleculetarget
DB05332RomiplostimThrombopoietin receptortarget
DB05394CorticorelinDopamine beta-hydroxylaseenzyme
DB05413TifuvirtidePlasma serine protease inhibitortarget
DB05434ABT-510Fibroblast growth factor 2target
DB05434ABT-510Hepatocyte growth factortarget
DB05434ABT-510Vascular endothelial growth factor Atarget
DB05434ABT-510Interleukin-8target
DB05446LJP 1082Beta-2-glycoprotein 1target
DB05459BriakinumabInterleukin-12 subunit betatarget
DB05459BriakinumabInterleukin-23 subunit alphatarget
DB05460EzatiostatGlutathione S-transferase Ptarget
DB05475GolotimodToll-like receptor 2target
DB05475GolotimodToll-like receptor 4target
DB05475GolotimodToll-like receptor 7target
DB05475GolotimodToll-like receptor 9target
DB05476WX-UK1Urokinase plasminogen activator surface receptortarget
DB05507VX-765Caspase-1target
DB05507VX-765Interleukin-1 betatarget
DB05521TelaprevirCytochrome P450 3A4enzyme
DB05521TelaprevirNS3/4A proteintarget
DB05521TelaprevirMultidrug resistance protein 1transporter
DB05521TelaprevirSerum albumincarrier
DB05521TelaprevirAlpha-1-acid glycoprotein 1carrier
DB05521TelaprevirSolute carrier organic anion transporter family member 1B1target
DB05521TelaprevirSolute carrier organic anion transporter family member 2B1target
DB05578RamucirumabVascular endothelial growth factor receptor 2target
DB05595FarletuzumabFolate receptor alphatarget
DB05675EP-2104RFibrinogen alpha chaintarget
DB05679UstekinumabInterleukin-12 subunit betatarget
DB05679UstekinumabInterleukin-23target
DB05687BL-1020D(2) dopamine receptortarget
DB05687BL-10205-hydroxytryptamine receptor 2Atarget
DB05713LY-517717Coagulation factor Xtarget
DB05739CYT006-AngQbType-1 angiotensin II receptortarget
DB05739CYT006-AngQbType-2 angiotensin II receptortarget
DB05773Trastuzumab emtansineReceptor tyrosine-protein kinase erbB-2target
DB05773Trastuzumab emtansineMultidrug resistance protein 1transporter
DB05773Trastuzumab emtansineCytochrome P450 3A4enzyme
DB05773Trastuzumab emtansineCytochrome P450 3A5enzyme
DB05777Thrombomodulin AlfaCoagulation factor Vtarget
DB05777Thrombomodulin AlfaProthrombintarget
DB05793PRO-542Free fatty acid receptor 4target
DB05797TNX-901High affinity immunoglobulin epsilon receptor subunit alphatarget
DB05829Parathyroid hormoneParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB05829Parathyroid hormoneParathyroid hormone 2 receptortarget
DB05864PPI-2458Methionine aminopeptidase 2target
DB05875substance PCytochrome P450 19A1enzyme
DB05875substance PCholinesteraseenzyme
DB05875substance PProstaglandin G/H synthase 2enzyme
DB05889Inotuzumab ozogamicinMultidrug resistance protein 1transporter
DB05889Inotuzumab ozogamicinB-cell receptor CD22target
DB05892RI 624Beta-nerve growth factortarget
DB05915MYO-029Growth/differentiation factor 8target
DB06043OlaratumabPlatelet-derived growth factor receptor alphatarget
DB06101IMC-1C11Vascular endothelial growth factor receptor 1target
DB06101IMC-1C11Vascular endothelial growth factor receptor 2target
DB06101IMC-1C11Vascular endothelial growth factor receptor 3target
DB06149TeicoplaninD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DB06151AcetylcysteineSolute carrier organic anion transporter family member 1B1transporter
DB06151AcetylcysteineNAPQI (N-acetyl-p-benzoquinone imine)target
DB06151AcetylcysteineSolute carrier family 22 member 6transporter
DB06151AcetylcysteineAminoacylase-1target
DB06151AcetylcysteineInhibitor of nuclear factor kappa-B kinase subunit alphatarget
DB06151AcetylcysteineInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB06151AcetylcysteineGlutathione synthetasetarget
DB06151AcetylcysteineCystine/glutamate transportertarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Btarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 1target
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Atarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 2Dtarget
DB06151AcetylcysteineGlutamate receptor ionotropic, NMDA 3Atarget
DB06168CanakinumabInterleukin-1 betatarget
DB06176RomidepsinCytochrome P450 3A4enzyme
DB06176RomidepsinCytochrome P450 3A5enzyme
DB06176RomidepsinMultidrug resistance protein 1transporter
DB06176RomidepsinSolute carrier organic anion transporter family member 1B3transporter
DB06176RomidepsinCytochrome P450 1A1enzyme
DB06176RomidepsinCytochrome P450 2B6enzyme
DB06176RomidepsinCytochrome P450 2C19enzyme
DB06176RomidepsinHistone deacetylase 1target
DB06176RomidepsinHistone deacetylase 2target
DB06176RomidepsinHistone deacetylase 4target
DB06176RomidepsinHistone deacetylase 6target
DB06176RomidepsinMultidrug resistance-associated protein 1target
DB06186IpilimumabCytotoxic T-lymphocyte protein 4target
DB06196IcatibantB2 bradykinin receptortarget
DB06196IcatibantAminopeptidase Ntarget
DB06243EflornithineOrnithine decarboxylasetarget
DB06262DroxidopaPhenylalanine-4-hydroxylasetarget
DB06262DroxidopaAlpha-1A adrenergic receptortarget
DB06262DroxidopaAlpha-1B adrenergic receptortarget
DB06262DroxidopaAlpha-1D adrenergic receptortarget
DB06262DroxidopaAlpha-2A adrenergic receptortarget
DB06262DroxidopaAlpha-2B adrenergic receptortarget
DB06262DroxidopaAlpha-2C adrenergic receptortarget
DB06262DroxidopaBeta-1 adrenergic receptortarget
DB06262DroxidopaBeta-2 adrenergic receptortarget
DB06262DroxidopaBeta-3 adrenergic receptortarget
DB06262DroxidopaAromatic-L-amino-acid decarboxylaseenzyme
DB06262DroxidopaMonocarboxylate transporter 10transporter
DB06262DroxidopaSodium-dependent noradrenaline transportertransporter
DB06273TocilizumabInterleukin-6 receptor subunit alphatarget
DB06285TeriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
DB06317ElotuzumabSLAM family member 7target
DB06335SaxagliptinDipeptidyl peptidase 4target
DB06335SaxagliptinCytochrome P450 3A4enzyme
DB06335SaxagliptinCytochrome P450 3A5enzyme
DB06335SaxagliptinMultidrug resistance-associated protein 1transporter
DB06335SaxagliptinSolute carrier organic anion transporter family member 4C1transporter
DB06335SaxagliptinSolute carrier family 22 member 8transporter
DB06366PertuzumabReceptor tyrosine-protein kinase erbB-2target
DB06372RilonaceptInterleukin-1 betatarget
DB06372RilonaceptInterleukin-1 alphatarget
DB06372RilonaceptInterleukin-1 receptor antagonist proteintarget
DB06404Human C1-esterase inhibitorComplement C1r subcomponenttarget
DB06404Human C1-esterase inhibitorComplement C1s subcomponenttarget
DB06404Human C1-esterase inhibitorPlasma kallikreintarget
DB06404Human C1-esterase inhibitorCoagulation factor XIItarget
DB06404Human C1-esterase inhibitorProthrombintarget
DB06404Human C1-esterase inhibitorCoagulation factor XItarget
DB06404Human C1-esterase inhibitorTissue-type plasminogen activatortarget
DB06612MepolizumabInterleukin-5target
DB06643DenosumabTumor necrosis factor ligand superfamily member 11target
DB06650OfatumumabB-lymphocyte antigen CD20target
DB06654SafinamideAmine oxidase [flavin-containing] Btarget
DB06654SafinamideAmine oxidase [flavin-containing] Aenzyme
DB06654SafinamideATP-binding cassette sub-family G member 2transporter
DB06654SafinamideSolute carrier organic anion transporter family member 3A1transporter
DB06654SafinamideCytochrome P450 3A4enzyme
DB06655LiraglutideGlucagon-like peptide 1 receptortarget
DB06655LiraglutideDipeptidyl peptidase 4enzyme
DB06655LiraglutideNeprilysinenzyme
DB06663PasireotideSomatostatin receptor type 1target
DB06663PasireotideSomatostatin receptor type 2target
DB06663PasireotideSomatostatin receptor type 3target
DB06663PasireotideSomatostatin receptor type 5target
DB06674GolimumabTumor necrosis factortarget
DB06681BelataceptT-lymphocyte activation antigen CD86target
DB06681BelataceptT-lymphocyte activation antigen CD80target
DB06692AprotininTrypsin-1target
DB06692AprotininChymotrypsinogen Btarget
DB06692AprotininPlasminogentarget
DB06692AprotininKallikrein-1target
DB06699DegarelixGonadotropin-releasing hormone receptortarget
DB06719BuserelinLutropin-choriogonadotropic hormone receptortarget
DB06719BuserelinGonadotropin-releasing hormone receptortarget
DB06719BuserelinCytochrome P450 19A1enzyme
DB06775Carglumic AcidCarbamoyl-phosphate synthase [ammonia], mitochondrialtarget
DB06785GanirelixGonadotropin-releasing hormone receptortarget
DB06788HistrelinGonadotropin-releasing hormone receptortarget
DB06791LanreotideSomatostatin receptor type 2target
DB06791LanreotideSomatostatin receptor type 5target
DB06823TioproninMyeloperoxidaseenzyme
DB06825TriptorelinGonadotropin-releasing hormone receptortarget
DB06827Viomycin70S ribosometarget
DB07744Z-Val-Ala-Asp fluoromethyl ketoneCaspase-1target
DB08508N-BENZOYL-D-ALANINEPenicillin-binding protein 1btarget
DB08626ThiorphanNeprilysintarget
DB08847HydroxyprolineProton-coupled amino acid transporter 1transporter
DB08862CholecystokininSolute carrier organic anion transporter family member 1B3transporter
DB08869TesamorelinGrowth hormone-releasing hormone receptortarget
DB08870Brentuximab vedotinTumor necrosis factor receptor superfamily member 8target
DB08870Brentuximab vedotinCytochrome P450 3A4enzyme
DB08870Brentuximab vedotinCytochrome P450 3A5enzyme
DB08870Brentuximab vedotinMultidrug resistance protein 1transporter
DB08872Gabapentin EnacarbilVoltage-dependent calcium channel subunit alpha-2/delta-1target
DB08872Gabapentin EnacarbilVoltage-dependent calcium channel subunit alpha-2/delta-2target
DB08872Gabapentin EnacarbilSodium-coupled monocarboxylate transporter 1transporter
DB08872Gabapentin EnacarbilSodium-dependent multivitamin transportertransporter
DB08873BoceprevirCytochrome P450 3A4enzyme
DB08873BoceprevirCytochrome P450 3A5enzyme
DB08873BoceprevirMultidrug resistance protein 1transporter
DB08873BoceprevirNS3/4A proteintarget
DB08879BelimumabTumor necrosis factor ligand superfamily member 13Btarget
DB08885AfliberceptVascular endothelial growth factor Atarget
DB08885AfliberceptPlacenta growth factortarget
DB08885AfliberceptVascular endothelial growth factor Btarget
DB08888OcriplasminAlpha-2-macroglobulintarget
DB08888OcriplasminAlpha-2-antiplasmintarget
DB08888OcriplasminFibronectintarget
DB08889CarfilzomibMultidrug resistance protein 1transporter
DB08889CarfilzomibProteasome subunit beta type-5target
DB08889CarfilzomibProteasome subunit beta type-9target
DB08889CarfilzomibProteasome subunit beta type-10target
DB08889CarfilzomibProteasome subunit beta type-8target
DB08889CarfilzomibProteasome subunit beta type-1target
DB08889CarfilzomibProteasome subunit beta type-2target
DB08890LinaclotideHeat-stable enterotoxin receptortarget
DB08892Arbaclofen PlacarbilMonocarboxylate transporter 1transporter
DB08892Arbaclofen PlacarbilGamma-aminobutyric acid type B receptor subunit 1target
DB08892Arbaclofen PlacarbilGamma-aminobutyric acid type B receptor subunit 2target
DB08894PeginesatideErythropoietin receptortarget
DB08900TeduglutideGlucagon-like peptide 2 receptortarget
DB08902RaxibacumabProtective antigentarget
DB08904Certolizumab pegolTumor necrosis factortarget
DB08935ObinutuzumabB-lymphocyte antigen CD20target
DB09029SecukinumabInterleukin-17Atarget
DB09033VedolizumabIntegrin alpha-4target
DB09033VedolizumabIntegrin beta-7target
DB09035NivolumabProgrammed cell death protein 1target
DB09036SiltuximabInterleukin-6target
DB09037PembrolizumabProgrammed cell death protein 1target
DB09043AlbiglutideGlucagon-like peptide 1 receptortarget
DB09045DulaglutideGlucagon-like peptide 1 receptortarget
DB09046MetreleptinLeptin receptortarget
DB09052BlinatumomabB-lymphocyte antigen CD19target
DB09052BlinatumomabT-cell surface glycoprotein CD3 delta chaintarget
DB09067Corticorelin ovine triflutateCorticotropin-releasing factor receptor 1target
DB09077DinutuximabGanglioside GD2target
DB09105Asfotase AlfaSphingosine 1-phosphate receptor 1target
DB09105Asfotase AlfaPyrophosphatetarget
DB09107Methoxy polyethylene glycol-epoetin betaErythropoietin receptortarget
DB09126Chorionic Gonadotropin (Human)Lutropin-choriogonadotropic hormone receptortarget
DB09137Technetium Tc-99m mebrofeninSolute carrier organic anion transporter family member 1B1transporter
DB09137Technetium Tc-99m mebrofeninSolute carrier organic anion transporter family member 1B3transporter
DB09264IdarucizumabDabigatran etexilatetarget
DB09265LixisenatideGlucagon-like peptide 1 receptortarget
DB09272EluxadolineMu-type opioid receptortarget
DB09272EluxadolineDelta-type opioid receptortarget
DB09272EluxadolineKappa-type opioid receptortarget
DB09272EluxadolineSolute carrier organic anion transporter family member 1B1transporter
DB09272EluxadolineCanalicular multispecific organic anion transporter 1transporter
DB09272EluxadolineSolute carrier family 22 member 8transporter
DB09292SacubitrilNeprilysintarget
DB09292SacubitrilSolute carrier organic anion transporter family member 1B1transporter
DB09292SacubitrilSolute carrier organic anion transporter family member 1B3transporter
DB09302AlirocumabProprotein convertase subtilisin/kexin type 9target
DB09303EvolocumabProprotein convertase subtilisin/kexin type 9enzyme
DB09331DaratumumabADP-ribosyl cyclase 1target
DB09357DexpanthenolMuscarinic acetylcholine receptor M3target
DB09421ProtirelinThyrotropin Releasing Hormone Receptortarget
DB09477EnalaprilatAngiotensin-converting enzymetarget
DB09477EnalaprilatB1 bradykinin receptortarget
DB09559NecitumumabEpidermal growth factor receptortarget
DB09564Insulin DegludecInsulin receptortarget
DB09570IxazomibCytochrome P450 3A4enzyme
DB09570IxazomibCytochrome P450 1A2enzyme
DB09570IxazomibCytochrome P450 2B6enzyme
DB09570IxazomibCytochrome P450 2C8enzyme
DB09570IxazomibCytochrome P450 2D6enzyme
DB09570IxazomibCytochrome P450 2C19enzyme
DB09570IxazomibCytochrome P450 2C9enzyme
DB11095DesirudinCarboxypeptidase A1enzyme
DB11256Levomefolic acidProton-coupled folate transportertransporter
DB11256Levomefolic acidFolate transporter 1transporter
DB11256Levomefolic acidMethionine synthaseenzyme
DB11300ThrombinProteinase-activated receptor 1target
DB11300ThrombinProteinase-activated receptor 4target
DB11311ProthrombinFibrinogen alpha chaintarget
DB11311ProthrombinFibrinogen beta chaintarget
DB11311ProthrombinCoagulation factor XIII A chaintarget
DB11311ProthrombinCarboxypeptidase B2target
DB11311ProthrombinCoagulation factor Xenzyme
DB11569IxekizumabInterleukin-17Atarget
DB11595AtezolizumabProgrammed cell death 1 ligand 1target
DB11598Antithrombin III humanAntithrombin-IIItarget
DB11611LifitegrastIntegrin alpha-Ltarget
DB11611LifitegrastCytochrome P450 2C9enzyme
DB11611LifitegrastSolute carrier organic anion transporter family member 1A2transporter
DB11611LifitegrastSolute carrier organic anion transporter family member 2B1transporter
DB11714DurvalumabProgrammed cell death 1 ligand 1target
DB11714DurvalumabT-lymphocyte activation antigen CD80target
DB11767SarilumabAlanine aminotransferase 1enzyme
DB11767SarilumabAlanine aminotransferase 2enzyme
DB11767SarilumabAspartate aminotransferaseenzyme
DB11767SarilumabCytochrome P450 3A4enzyme
DB11767SarilumabInterleukin-6 receptor subunit alphatarget
DB11767SarilumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB11767SarilumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB11781TosedostatPuromycin-sensitive aminopeptidasetarget
DB11781TosedostatLeukotriene A-4 hydrolasetarget
DB11834GuselkumabInterleukin-23 subunit alphatarget
DB11854AstodrimerEnvelope glycoprotein gp160target
DB11915Valbenazinevesicular monoamine transporter 2 (VMAT2)target
DB11915ValbenazineCytochrome P450 2D6enzyme
DB11915ValbenazineCytochrome P450 3A4enzyme
DB11915ValbenazineCytochrome P450 3A5enzyme
DB11945AvelumabProgrammed cell death 1 ligand 1target
DB11988OcrelizumabB-lymphocyte antigen CD20target
DB12095TelotristatTryptophan 5-hydroxylase 2target
DB12095TelotristatTryptophan 5-hydroxylase 1target
DB12118SotaterceptActivin receptor type-2Atarget
DB12119GevokizumabInterleukin-1 betatarget
DB12159DupilumabInterleukin-4 receptor subunit alphatarget
DB12250CixutumumabInsulin-like growth factor 1 receptortarget
DB12698IbalizumabFree fatty acid receptor 4target
DB12865EtelcalcetideExtracellular calcium-sensing receptortarget
DB13074MacimorelinGrowth hormone secretagogue receptor type 1target
DB13144LenograstimGranulocyte colony-stimulating factor receptortarget
DB13149Protein S humanCoagulation factor Vtarget
DB13149Protein S humanCoagulation factor Xtarget
DB13149Protein S humanVitamin K-dependent protein Ctarget
DB13150Coagulation factor VII humanTissue factortarget
DB13150Coagulation factor VII humanCoagulation factor Xtarget
DB13150Coagulation factor VII humanCoagulation factor IXtarget
DB13166ZofenoprilAngiotensin-converting enzymetarget
DB13191PhosphocreatineGuanidinoacetate N-methyltransferasetarget
DB13191PhosphocreatineSodium- and chloride-dependent creatine transporter 1target
DB13191PhosphocreatineCreatine kinase M-typetarget
DB13191PhosphocreatineCreatine kinase U-type, mitochondrialtarget
DB13191PhosphocreatineCreatine kinase S-type, mitochondrialtarget
DB13191PhosphocreatineCreatine kinase B-typetarget